1
|
Ahmed E, Assou S, Foisset F, Bourdais C, Vanheerswynghels M, Petit A, Gamez AS, Gras D, Chanez P, de Vos J, Hammad H, Bourdin A, Lambrecht B. [Modeling T2 high severe asthma using human induced pluripotent stem cells (hiPSC)]. Rev Mal Respir 2024; 41:289-293. [PMID: 38461089 DOI: 10.1016/j.rmr.2024.02.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2024] [Accepted: 02/05/2024] [Indexed: 03/11/2024]
Abstract
Severe asthma patients with persistent airflow obstruction are characterized by functional obstruction due to mucus plugs containing mucins, fibrin, and eosinophil derived Charcot- Leyden crystals. The molecular mechanisms underlying this endotype are not clearly understood. Developing new models is crucial to respiratory research insofar as critical differences exist between human and rodent airway epithelium. We (and other teams) have shown that it is possible to reconstitute in vitro a complex and functional airway epithelium displaying all the features described in vivo from human-induced pluripotent stem cells (hiPSC). Our aim is to establish a human in vitro model of severe asthma that will recapitulate airway epithelium remodeling and mucus plugs.
Collapse
Affiliation(s)
- E Ahmed
- Laboratoire d'immunologie muqueuse, centre VIB-UGent pour la recherche sur l'inflammation, université de Gand, 9000 Gand, Belgique; Département de maladies respiratoires, université de Montpellier, CHU de Montpellier, hôpital Arnaud de Villeneuve, Montpellier, France
| | - S Assou
- IRMB, Université de Montpellier, INSERM, CHU de Montpellier, Montpellier, France
| | - F Foisset
- IRMB, Université de Montpellier, INSERM, CHU de Montpellier, Montpellier, France
| | - C Bourdais
- IRMB, Université de Montpellier, INSERM, CHU de Montpellier, Montpellier, France
| | - M Vanheerswynghels
- Laboratoire d'immunologie muqueuse, centre VIB-UGent pour la recherche sur l'inflammation, université de Gand, 9000 Gand, Belgique
| | - A Petit
- Département de maladies respiratoires, université de Montpellier, CHU de Montpellier, hôpital Arnaud de Villeneuve, Montpellier, France
| | - A S Gamez
- Département de maladies respiratoires, université de Montpellier, CHU de Montpellier, hôpital Arnaud de Villeneuve, Montpellier, France
| | - D Gras
- Aix-Marseille université, INSERM, INRAE, C2VN, Marseille, France
| | - P Chanez
- Aix-Marseille université, INSERM, INRAE, C2VN, Marseille, France
| | - J de Vos
- IRMB, Université de Montpellier, INSERM, CHU de Montpellier, Montpellier, France
| | - H Hammad
- Laboratoire d'immunologie muqueuse, centre VIB-UGent pour la recherche sur l'inflammation, université de Gand, 9000 Gand, Belgique
| | - A Bourdin
- Département de maladies respiratoires, université de Montpellier, CHU de Montpellier, hôpital Arnaud de Villeneuve, Montpellier, France; PhyMedExp, université de Montpellier, INSERM, CHU de Montpellier, Montpellier, France.
| | - B Lambrecht
- Laboratoire d'immunologie muqueuse, centre VIB-UGent pour la recherche sur l'inflammation, université de Gand, 9000 Gand, Belgique; Département de médecine interne et pédiatrie, université de Gand, Gand, Belgique
| |
Collapse
|
2
|
Annesi-Maesano I, Bonniaud P, Bouchaud G, Boyer L, Gazzeri S, Gosset P, Gras D, Guibert C, Guignabert C, Mari B, Matecki S, Morélot C, Pilette C, Planes C, Plantier L, Polette M, Si-Tahar M, Taillé C, Vachier I. [Triumphant return of the J2R 2023 at Tours: A whirlwind of scientific exchanges and emotion]. Rev Mal Respir 2024; 41:180-182. [PMID: 38514243 DOI: 10.1016/j.rmr.2024.03.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/23/2024]
Affiliation(s)
- I Annesi-Maesano
- Institut Desbrest d'épidémiologie et santé publique (IDESP), Inserm, université de Montpellier, Montpellier, France
| | - P Bonniaud
- Service de pneumologie et soins intensifs respiratoires, Inserm UMR 1231, Centre de référence constitutif des maladies pulmonaires rares de l'adulte, centre hospitalo-universitaire de Dijon-Bourgogne, UFR des sciences de santé, université de Bourgogne-Franche Comté, Dijon, France
| | | | - L Boyer
- Service de physiologie, hôpital Henri-Mondor, AP-HP, université Paris Est Créteil, Inserm, IMRB, Créteil, France
| | - S Gazzeri
- Institut pour l'avancée des biosciences (IAB), Inserm U1209, CNRS UMR 5309, université Grenoble Alpes, La Tronche, France
| | - P Gosset
- CNRS UMR9017, Inserm U1019, Institut Pasteur de Lille, Center for Infection and Immunity of Lille (CIIL), CHRU de Lille, université de Lille, Lille, France
| | - D Gras
- Aix-Marseille université, Inserm, INRAE, C2VN, Marseille, France
| | - C Guibert
- Inserm, Centre de recherche cardiothoracique de Bordeaux, U1045, Pessac, université de Bordeaux, Bordeaux, France
| | - C Guignabert
- Inserm, hypertension pulmonaire : physiopathologie et innovation thérapeutique, université Paris-Saclay, 92350 Le Plessis-Robinson, France
| | - B Mari
- CNRS, Institut de pharmacologie moléculaire et cellulaire (IPMC), université Côte d'Azur, Sophia-Antipolis, France
| | - S Matecki
- PHYMEDEXP, UMR CNRS 9214, Inserm U1046, université de Montpellier, CHU de Montpellier, Montpellier, France
| | - C Morélot
- Service de pneumologie, département R3S, GHU, AP-HP-Sorbonne université, site Pitié-Salpêtrière, UMR-S 1158 Inserm, neurophysiologie respiratoire expérimentale et clinique, Paris cedex 13, France
| | - C Pilette
- Service de pneumologie, cliniques universitaires Saint-Luc, pôle pneumologie, ORL et dermatologie, Institut de recherche expérimentale et clinique, UCLouvain, Louvain, Belgique
| | - C Planes
- Service de physiologie-explorations fonctionnelles, hôpital Avicenne, HUPSSD, AP-HP, « Hypoxie & Poumon » Inserm U1272, UFR SMBH Bobigny, université Sorbonne Paris Nord, Paris, France
| | - L Plantier
- Service de pneumologie et exploration fonctionnelle respiratoire, CEPR/Inserm UMR1100, CHRU de Tours, université de Tours, Tours, France
| | - M Polette
- Inserm UMR-S 1250, université de Reims Champagne-Ardenne, Reims, France
| | - M Si-Tahar
- Inserm, Centre d'étude des pathologies respiratoires (CEPR), UMR 1100, université de Tours, Tours, France
| | - C Taillé
- Service de pneumologie et centre de référence constitutif des maladies pulmonaires rares, Inserm UMR1152, AP-HP Nord, université de Paris, Paris, France
| | - I Vachier
- Département de pneumologie, médecine biologie méditerranée, CHU de Montpellier, Montpellier, France.
| |
Collapse
|
3
|
Garcia R, Mansourati J, Gras D, Probst V, Khattar P, Himbert C, Gandjbakhch E, Saulnier PJ, Constantin V, Lequeux B, Gueffet JP, Combes S, Minois D, Gras M, Bisson A, Pierre B, Defaye P, Marijon E, Boveda S, Degand B. Rationale and design of the HeartLogic French Cohort Study: Remote monitoring of heart failure patients implanted with a cardiac defibrillator enabled with the HeartLogic algorithm. Archives of Cardiovascular Diseases Supplements 2023. [DOI: 10.1016/j.acvdsp.2022.10.186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
|
4
|
Garcia R, Mansourati J, Gras D, Probst V, Khattar P, Himbert C, Saulnier PJ, Constantin-Jacquot V, Gueffet JP, Minois D, Pierre B, Defaye P, Marijon E, Boveda S, Degand B. Evaluation of a multisensory algorithm to prevent acute decompensation of heart failure in patients implanted with a cardioverter defibrillator: rationale and design. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.428] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Heart failure (HF) is a chronic disease affecting 64 million people worldwide and places a severe burden on society because of its mortality, numerous re-hospitalizations and associated costs [1–4]. HeartLogic is an algorithm incorporating several biometric parameters which aims to predict HF episodes. It provides an index which can be monitored remotely, allowing preemptive treatment of congestion to prevent acute decompensation [5–7].
Objectives
We aim to provide real-world data on the impact of pre-emptive HF management, guided by the HeartLogic index on unscheduled HF hospitalizations in a substantial cohort of patients.
Methods
The HeartLogic French Study is an investigator-initiated, prospective, multi-centre, non-randomized study. All in all, 310 patients with a history of HF (left ventricular ejection fraction ≤40%; or at least one episode of clinical HF with elevated NT-proBNP ≥450 ng/L) and implanted with a cardioverter defibrillator enabling HeartLogic index calculation will be included across 10 French centers. The HeartLogic index will be monitored remotely on a weekly basis for 12 months and in case of HeartLogic index ≥16, the local investigator will contact the patient for assessment and adjust HF treatment as necessary. The primary endpoint is unscheduled hospitalization for HF. Secondary endpoints are all-cause mortality, cardiovascular death, HF-related death, and unscheduled hospitalizations for ventricular or atrial arrhythmia. Blood samples will be collected for biobanking, and quality of life will be assessed. A blind and independent committee will adjudicate the events.
Conclusions
The HeartLogic French Cohort Study will provide robust real-world data on HF hospitalization in a cohort of patients managed with the HeartLogic algorithm allowing preemptive treatment of congestion.
Funding Acknowledgement
Type of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): Boston Scientific
Collapse
Affiliation(s)
- R Garcia
- University Hospital of Poitiers, Department of cardiology , Poitiers , France
| | - J Mansourati
- University Hospital of Brest, Cardiology , Brest , France
| | - D Gras
- Hôpital Privé du Confluent, Cardiology , Nantes , France
| | - V Probst
- University Hospital of Nantes, Cardiology , Nantes , France
| | - P Khattar
- Centre Hospitalier de Bretagne Sud, Cardiology , Lorient , France
| | - C Himbert
- Hospital Pitie-Salpetriere, Cardiology , Paris , France
| | - P J Saulnier
- University Hospital of Poitiers, Centre d'Investigation Clinique 1402 , Poitiers , France
| | | | - J P Gueffet
- Hôpital Privé du Confluent, Cardiology , Nantes , France
| | - D Minois
- University Hospital of Nantes, Cardiology , Nantes , France
| | - B Pierre
- University Hospital of Tours, Cardiology , Tours , France
| | - P Defaye
- University Hospital of Grenoble, Cardiology , Grenoble , France
| | - E Marijon
- European Hospital Georges Pompidou, Cardiology , Paris , France
| | - S Boveda
- Clinic Pasteur, Cardiology , Toulouse , France
| | - B Degand
- University Hospital of Poitiers, Department of cardiology , Poitiers , France
| |
Collapse
|
5
|
Starek Z, Di Cori A, Betts T, Clerici G, Gras D, Lyan E, Della Bella P, Li J, Hack B, Zitella Verbick L, Sommer P. Low voltage area as a predictor of recurrence after a single pulmonary vein isolation procedure: results of the WAVE-MAP AF study. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.585] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background/Introduction
Pulmonary vein isolation (PVI) is a recommended approach for atrial fibrillation (AF) ablation procedures. Substrate modification beyond PVI has mixed results but identifying and ablating low voltage zones and ablating those targets in addition to PVI may be beneficial. Electroanatomic mapping is critical to identify subjects that may require further substrate modification. Low voltage area may be predictive of optimal treatment approach.
Purpose
This was a prospective, multicenter, interventional study of a high-density grid-style mapping catheter (HD Grid) to characterize left atrial low voltage substrate during sinus rhythm (SR) and AF and identify associations with 12 month recurrence rates after a single de novo radiofrequency (RF) ablation using a PVI only approach.
Methods
This study (NCT03882021) enrolled 300 subjects at 18 centers in Europe and Israel. Subjects underwent de novo RF ablation for paroxysmal AF (PAF) (N=113), early persistent AF (PsAF; AF sustained 7 days to 3 months) (N=86) or non-early PsAF (AF sustained >3 months to 12 months) (N=101). High density voltage maps were collected with HD Grid. Two pre-ablation maps, in SR and AF, were created for each subject (N=196) followed by PVI only ablation. Low voltage area (using cutoffs of 0.1 mV to 1.5 mV) was investigated in SR and AF. Follow up visits were at 3, 6 and 12 months post-ablation, with a 24-hour Holter monitor at 12 months. A Cox proportional hazards model was used to identify associations between mapping data and 12 month AF/atrial flutter (AFL)/atrial tachycardia (AT) recurrence after a single PVI procedure.
Results
At 12 months, 75.5% of subjects were free from AF/AFL/AT recurrence. On average, PsAF subjects had more low voltage area than PAF subjects in SR and AF. However, while univariate analysis found no correlation between recurrence and PAF or PsAF diagnosis (p=0.1261), those with recurrence had a significantly larger percent left atrial low voltage area under 0.5 mV with simultaneous orthogonal bipole wave configuration (HDW) in both AF (p=0.0011) and SR (p=0.0210) than those without recurrence. Using HDW, low voltage area (identified as <0.5 mV) greater than 28% of the left atrium in SR (HR: 4.82, 95% CI: 2.08–11.18, p=0.0003) and greater than 72% in AF (HR: 5.66, 95% CI: 2.34–13.69, p=0.0001) were associated with a higher risk of AF/AFL/AT recurrence at one year.
Conclusion(s)
Using a standard cutoff of 0.5 mV, a larger percent low voltage area was associated with increased risk of recurrence in both SR and AF. Future analyses will explore optimal low voltage cutoffs and thresholds predictive of recurrence that may necessitate additional substrate modification beyond PVI.
Funding Acknowledgement
Type of funding sources: Private company. Main funding source(s): Abbott
Collapse
Affiliation(s)
- Z Starek
- St. Anne University Hospital Brno (FNUSA) , Brno , Czechia
| | - A Di Cori
- Azienda Ospedaliero Universitaria Pisana , Pisa , Italy
| | - T Betts
- John Radcliffe Hospital , Oxford , United Kingdom
| | - G Clerici
- Centre Hospitalier Universitaire de La Reunion , La Réunion , France
| | - D Gras
- Hôpital Privé du Confluent , Nantes , France
| | - E Lyan
- Cardiovascular Center Bad Bevensen , Bad Bevensen , Germany
| | | | - J Li
- Abbott , Saint Paul , United States of America
| | - B Hack
- Abbott , Saint Paul , United States of America
| | | | - P Sommer
- Heart and Diabetes Center NRW , Bad Oeynhausen , Germany
| |
Collapse
|
6
|
Garcia Bolao I, Gras D, D'Onofrio A, Mark G, Nair D, Lellouche N, Novak M, Lo R, Chew E, Wright D, Kaplan A, Veraghtert S, Hu Y, Yong P, Gardner RS. Strategic management to optimize response to cardiac resynchronization therapy registry. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.730] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Cardiac resynchronization therapy (CRT) is guideline-recommended for the treatment of symptomatic heart failure (HF) in patients (pts) with reduced LVEF and prolonged QRS. Clinical trials report Clinical Composite Score (CCS) response rates from 60 to 75%. However, patients with common comorbidities, such as atrial fibrillation, are often under-represented in clinical trials. The Strategic MAnagement to optimize response to cardiac Resynchronization Therapy (SMART) Registry (NCT03075215) was designed to examine outcomes in CRT patients in the real world.
Methods
The SMART Registry was a global, multicenter, prospective, clinical registry that enrolled subjects undergoing a de novo CRT-D implant or upgrade from pacemaker to CRT-D using a quadripolar LV lead. CCS was assessed at 12 months post-implant.
Results
For study design and CCS outcomes see Figure 1. CCS at 12 months showed that 58.8% of pts improved and 20.1% stabilized. Of the 21.1% of pts that worsened, 8.4% were due to death, 7.8% non-fatal heart failure event, and 5% worsening of NYHA or patient global assessment. Notably, this registry had a high prevalence of pts with NYHA I/II (51%), Non-LBBB (50%), AF (37%), diabetes (35%), and bradycardia (31%) at baseline. Age (>65), diabetes, ischemia, non-LBBB, atrial fibrillation (AF) and renal dysfunction correlated with worsened CCS outcomes. NYHA III/IV patients had significantly higher HF hospitalization (HFH) rates than NYHA I/II (P-value <0.001) (Figure 2a) and patients with AF had higher HFH rates than those without (P-value <0.001) (Figure 2b). Similar effects of NYHA score and AF were seen on mortality. The use of ACE/ARB, or ARNI, and MRA correlated with better outcomes, whereas diuretics and anticoagulants correlated with poorer outcomes.
Conclusions
In this large registry, clinical outcomes across important sub-populations are in line with expectations, with older age, ischemia, renal dysfunction, AF, non-LBBB, and diabetes associated with a lower likelihood of response to CRT. By including these patients, this study provides a clearer picture of the effectiveness of CRT in the real world. Future studies should examine optimization approaches to facilitate CRT effectiveness in these under studied patient populations.
Funding Acknowledgement
Type of funding sources: Private company. Main funding source(s): This registry was funded by Boston Scientific (BSC)
Collapse
Affiliation(s)
| | - D Gras
- L'Hopital Prive du Confluent , Nantes , France
| | - A D'Onofrio
- AORN Ospedali dei Colli - Monaldi Hospital , Naples , Italy
| | - G Mark
- Cardiology Associates of the Delaware Valley, PA , Haddon Heights , United States of America
| | - D Nair
- Arrhythmia Research Group , Jonesboro , United States of America
| | | | - M Novak
- Faculty Hospital U sv Anny , Brno , Czechia
| | - R Lo
- VA Loma Linda , Loma Linda , United States of America
| | - E Chew
- Belfast City Hospital Trust , Belfast , United Kingdom
| | - D Wright
- Liverpool Heart and Chest Hospital , Liverpool , United Kingdom
| | - A Kaplan
- Cardiovascular Associates of Mesa , Mesa , United States of America
| | - S Veraghtert
- Boston Scientific Corporation , St. Paul , United States of America
| | - Y Hu
- Boston Scientific Corporation , St. Paul , United States of America
| | - P Yong
- Boston Scientific Corporation , St. Paul , United States of America
| | - R S Gardner
- Golden Jubilee National Hospital, Scottish National Advanced Heart Failure Service , Clydebank , United Kingdom
| |
Collapse
|
7
|
Starek Z, Di Cori A, Betts T, Clerici G, Gras D, Lyan E, Li J, Hack B, Zitella Verbick L, Sommer P. High density wave mapping to characterize low voltage substrate in sinus rhythm and atrial fibrillation: acute results from the WAVE-MAP AF study. Europace 2022. [DOI: 10.1093/europace/euac053.238] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Private company. Main funding source(s): Abbott
Background
Pulmonary vein isolation (PVI) is a recommended approach for all atrial fibrillation (AF) ablation procedures, but PVI alone does not cure all AF. Supplementary substrate modification beyond PVI has mixed results. Identifying low voltage zones and ablating those targets in addition to PVI may be beneficial. Electroanatomic mapping is critical to identify subjects that may require further substrate modification. The amount of low voltage area may be predictive of the optimal treatment approach.
Purpose
This was a prospective, multicenter, interventional study of a high-density grid-style mapping catheter (HD Grid) to characterize left atrial (LA) low voltage substrate during sinus rhythm (SR) and AF in subjects undergoing de novo radiofrequency (RF) ablation for paroxysmal AF (PAF), early persistent AF (PsAF) (7 days-3 months) or non-early PsAF (>3 months-12 months) using a PVI only approach.
Methods
High-density voltage maps were collected with HD Grid during both SR and AF prior to ablation. Differences in low voltage area between (1) SR and AF and (2) simultaneous orthogonal bipole wave configuration (HDW) and standard along-the-spline linear electrode configuration (SD) were investigated.
Results
Three hundred subjects, enrolled at 18 centers in Europe and Israel, underwent PVI only RF ablation for PAF (N=113), early PsAF (N=79), and non-early PsAF (N=108). The average age was 62.0 ± 9.5 years and 70.3% (211/300) were male. SR maps and AF maps were available and evaluated in HDW and SD for 196 subjects (65.3%) (63 PAF, 65 early PsAF, 68 non-early PsAF). Mean LA surface area was 108.8 cm² and mean mapped surface area ranged from 83.2 to 89.5 cm².
HDW maps showed less low voltage area compared to SD in all subgroups, both in AF and in SR (Figure). For example, in AF with a low voltage cutoff of 0.5 mV, mean low voltage area was 49.8 cm² using SD and only 45.6 cm² using HDW (p<.0001). Similarly, in SR with a low voltage cutoff of 0.5 mV, mean low voltage area was 16.1 cm² using SD and only 12.6 cm² using HDW (p<.0001). HDW showed significantly less low voltage area than SD in SR for all measured voltage cutoffs from 0.1 mV to 1.5 mV.
On average, non-early PsAF subjects had a larger low voltage area than early PsAF subjects and PAF subjects in both SR and AF. In SR HDW, non-early PsAF subjects had 15.6 cm² under 0.5 mV, early PsAF subjects had 12.4 cm², and PAF subjects had 9.2 cm² (p=.0316). In AF HDW, non-early PsAF subjects had 56.6 cm² under 0.5 mV, early PsAF had 42.8 cm² and PAF subjects had 35.4 cm² (p<.0001).
Conclusion
Non-early PsAF subjects had the largest low voltage area on average compared to both early PsAF and PAF subjects in this study. Using HD grid, HDW provided better low voltage area characterization compared to SD in both SR and AF. The final results of this study will suggest whether an HDW substrate characterization of low voltage area can predict recurrences after a single PVI-only strategy procedure.
Collapse
Affiliation(s)
- Z Starek
- St. Anne University Hospital Brno (FNUSA), Brno, Czechia
| | - A Di Cori
- Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
| | - T Betts
- John Radcliffe Hospital, Oxford, United Kingdom of Great Britain & Northern Ireland
| | - G Clerici
- Centre Hospitalier Universitaire de La Reunion, La Réunion, France
| | - D Gras
- Hôpital Privé du Confluent, Nantes, France
| | - E Lyan
- Cardiovascular Center Bad Bevensen, Bad Bevensen, Germany
| | - J Li
- Abbott, Saint Paul, United States of America
| | - B Hack
- Abbott, Saint Paul, United States of America
| | | | - P Sommer
- Heart and Diabetes Center NRW, Bad Oeynhausen, Germany
| |
Collapse
|
8
|
Annesi-Maesano I, Bonniaud P, Bouchaud G, Boyer L, Gazzeri S, Gosset P, Gras D, Guibert C, Guignabert C, Mari B, Matecki S, Morélot C, Pilette C, Planes C, Plantier L, Polette M, Si-Tahar M, Taillé C, Vachier I. RESPIRenT : RESeau de Pneumologie en Innovation et Recherche translaTionnelle, un nouveau souffle pour les J2R. Rev Mal Respir 2022; 39:73-74. [DOI: 10.1016/j.rmr.2022.01.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2022] [Accepted: 01/05/2022] [Indexed: 11/27/2022]
|
9
|
Valette K, Moreno L, Duez C, Chanez P, Gras D. Influence of culture expansion medium on human bronchial epithelium composition and function. Rev Mal Respir 2022. [DOI: 10.1016/j.rmr.2022.02.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
10
|
Chebbo M, Assou S, Pantesco V, Duez C, Chanez P, Gras D. Molecular portrait of platelets from patients with severe asthma. Rev Mal Respir 2021. [DOI: 10.1016/j.rmr.2021.02.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
11
|
Annesi-Maesano I, Bonniaud P, Bouchaud G, Boyer L, Frossard N, Gazzeri S, Gosset P, Gras D, Guibert C, Guignabert C, Mari B, Matecki S, Morelot C, Pilette C, Planes C, Plantier L, Polette M, Si-Tahar M, Taillé C, Vachier I. [Tonnerre de Brest! 2020 Respiratory Research Days like no others…]. Rev Mal Respir 2021; 38:565-566. [PMID: 34024643 DOI: 10.1016/j.rmr.2021.05.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2021] [Accepted: 03/30/2021] [Indexed: 11/16/2022]
Affiliation(s)
- I Annesi-Maesano
- Institut Desbrest d'Épidémiologie et Santé Publique (IDESP), Inserm - Université de Montpellier, Montpellier, France
| | - P Bonniaud
- Centre de Référence Constitutif des Maladies Pulmonaires Rares de l'Adulte, Service de Pneumologie et Soins Intensifs Respiratoires, Centre Hospitalo-Universitaire de Dijon-Bourgogne - UFR des Sciences de Santé, Université de Bourgogne-Franche Comté - Inserm UMR 1231, Dijon, France
| | | | - L Boyer
- Service de Physiologie, Hôpital Henri Mondor, AP-HP, Univ Paris Est Creteil, Inserm, IMRB, Creteil, France
| | - N Frossard
- Laboratoire d'Innovation Thérapeutique, UMR 7200 CNRS - Université de Strasbourg, Illkirch, France
| | - S Gazzeri
- RNA Splicing, Cell Signaling and Response to Therapies Team Centre de recherche UGA, Inserm U1209, CNRS UMR 5309, La Tronche, France
| | - P Gosset
- University Lille, CNRS UMR9017, Inserm U1019, CHRU Lille, Institut Pasteur de Lille, CIIL - Center for Infection and Immunity of Lille, Lille, France
| | - D Gras
- Aix-Marseille Univ, Inserm, INRAE, C2VN, Marseille, France
| | - C Guibert
- Inserm, Centre de Recherche Cardio-Thoracique de Bordeaux, U1045, Pessac - Université de Bordeaux, Bordeaux, France
| | - C Guignabert
- Inserm UMR_S 999 « Pulmonary Hypertension : Pathophysiology and Novel Therapies », Hôpital Marie Lannelongue, Le Plessis-Robinson - Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France
| | - B Mari
- Université Côte d'Azur, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire (IPMC), Sophia Antipolis, France
| | - S Matecki
- PHYMEDEXP, UMR CNRS 9214, Inserm U1046-Université de Montpellier Montpellier - CHU Montpellier, Montpellier, France
| | - C Morelot
- Service de Pneumologie, Département R3S, GHU, APHP-Sorbonne Université, site Pitié Salpêtrière - UMR-S 1158 Inserm - Sorbonne Université, Neurophysiologie Respiratoire Expérimentale et Clinique, Paris Cedex 13, France
| | - C Pilette
- Service de pneumologie, Cliniques universitaires Saint-Luc - Pôle pneumologie, ORL et dermatologie, Institut de Recherche Expérimentale et Clinique, UCLouvain, Louvain, Belgique
| | - C Planes
- Service de Physiologie-Explorations Fonctionnelles, Hôpital Avicenne, HUPSSD, AP-HP - "Hypoxie & Poumon" Inserm U1272, UFR SMBH Bobigny, Université Sorbonne Paris Nord, Paris, France
| | - L Plantier
- Service de Pneumologie et Exploration Fonctionnelle Respiratoire, CHRU de Tours - CEPR/Inserm UMR1100, Université de Tours, Tours, France
| | - M Polette
- Inserm UMR-S 1250, Université de Reims Champagne-Ardenne, Reims, France
| | - M Si-Tahar
- Inserm, Centre d'Étude des Pathologies Respiratoires (CEPR), UMR 1100 - Université de Tours, Tours, France
| | - C Taillé
- Service de pneumologie et centre de référence constitutif des maladies pulmonaires rares, AP-HP Nord - Université de Paris, Paris, France
| | - I Vachier
- Coordinatrice du groupe J2R (-) Département de Pneumologie, CHU Montpellier, Médecine Biologie Méditerranée, Montpellier, France.
| | | |
Collapse
|
12
|
Dacher JN, Gandjbakhch E, Taieb J, Chauvin M, Anselme F, Bartoli A, Boyer L, Cassagnes L, Cochet H, Dubourg B, Fauchier L, Gras D, Klug D, Laurent G, Mansourati J, Marijon E, Maury P, Piot O, Pontana F, Sacher F, Sadoul N, Boveda S, Jacquier A. Joint Position Paper of the Working Group of Pacing and Electrophysiology of the French Society of Cardiology (SFC) and the Société française d'imagerie cardiaque et vasculaire diagnostique et interventionnelle (SFICV) on magnetic resonance imaging in patients with cardiac electronic implantable devices. Diagn Interv Imaging 2020; 101:507-517. [PMID: 32094095 DOI: 10.1016/j.diii.2020.02.003] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2020] [Revised: 02/02/2020] [Accepted: 02/03/2020] [Indexed: 11/15/2022]
Abstract
Magnetic resonance imaging (MRI) has become the reference imaging for the management of a large number of diseases. The number of MR examinations increases every year, simultaneously with the number of patients receiving a cardiac electronic implantable device (CEID). A CEID was considered an absolute contraindication for MRI for years. The progressive replacement of conventional pacemakers and defibrillators by MR-conditional CEIDs and recent data on the safety of MRI in patients with "MR-nonconditional" CEIDs have progressively increased the demand for MRI in patients with a CEID. However, some risks are associated with MRI in CEID carriers, even with "MR-conditional" devices because these devices are not "MR-safe". A specific programing of the device in "MR-mode" and monitoring patients during MRI remain mandatory for all patients with a CEID. A standardized patient workflow based on an institutional protocol should be established in each institution performing such examinations. This joint position paper of the Working Group of Pacing and Electrophysiology of the French Society of Cardiology and the Société française d'imagerie cardiaque et vasculaire diagnostique et interventionnelle (SFICV) describes the effect and risks associated with MRI in CEID carriers. We propose recommendations for patient workflow and monitoring and CEID programming in MR-conditional, "MR-conditional nonguaranteed" and MR-nonconditional devices.
Collapse
Affiliation(s)
- J-N Dacher
- Normandie UNIV, UNIROUEN, Inserm U1096, CHU Rouen, Department of Radiology, Cardiac Imaging Unit, 76000 Rouen, France.
| | - E Gandjbakhch
- Sorbonne Universités, AP-HP, Heart Institute, La Pitié-Salpêtrière University Hospital, 75013 Paris, France
| | - J Taieb
- Hospital of Aix-en-Provence, Department of Cardiology, 13100 Aix-en-Provence, France
| | - M Chauvin
- Université de Strasbourg, CHU Strasbourg, Department of Cardiology, 67000 Strasbourg, France
| | - F Anselme
- Normandie UNIV, UNIROUEN, CHU Rouen, Department of Cardiology, 76000 Rouen, France
| | - A Bartoli
- Université Aix-Marseille, Centre Hospitalo-Universitaire Timone, AP-HM, Department of Radiology, CNRS, CRMBM, CEMEREM, 13005 Marseille, France
| | - L Boyer
- Université Clermont Auvergne, CHU Clermont-Ferrand, Department of Radiology, 63000 Clermont-Ferrand, France
| | - L Cassagnes
- Université Clermont Auvergne, CHU Clermont-Ferrand, Department of Radiology, 63000 Clermont-Ferrand, France
| | - H Cochet
- Université de Bordeaux-Inserm, IHU LIRYC, CHU de Bordeaux, Department of Cardiovascular Imaging, Hôpital Cardiologique du Haut-Lévêque, 33600 Pessac, France
| | - B Dubourg
- Normandie UNIV, UNIROUEN, Inserm U1096, CHU Rouen, Department of Radiology, Cardiac Imaging Unit, 76000 Rouen, France
| | - L Fauchier
- Université de Tours, CHU de Tours, Department of Cardiology, 37000 Tours, France
| | - D Gras
- Nouvelles Cliniques Nantaises, Department of Cardiology, 44200 Nantes, France
| | - D Klug
- Université de Lille, CHRU de Lille, Department of Cardiology, 59000 Lille, France
| | - G Laurent
- Université de Dijon, CHU de Dijon, Department of Cardiology, 21000 Dijon, France
| | - J Mansourati
- Université de Bretagne Occidentale, CHU de Brest, Department of Cardiology, 29200 Brest, France
| | - E Marijon
- Université de Paris, AP-HP, Department of Cardiology, Georges-Pompidou European University Hospital, 75015 Paris, France
| | - P Maury
- Université de Toulouse, Inserm U1048, Department of Cardiology, Hospital Rangueil, 31059 Toulouse, France
| | - O Piot
- Centre Cardiologique du Nord, Department of Cardiology, 93200 Saint-Denis, France
| | - F Pontana
- Université de Lille, Inserm U1011, Department of Cardiovascular Radiology, Institut Cœur-Poumon, 59000 Lille, France
| | - F Sacher
- Université de Bordeaux-Inserm, IHU LIRYC, CHU de Bordeaux, Department of Cardiology, Hôpital Cardiologique du Haut-Lévêque, CHU de Bordeaux, 33600 Pessac, France
| | - N Sadoul
- Université de Nancy Lorraine, CHU de Nancy, Department of Cardiology, 54511 Vandœuvre-lès-Nancy, France
| | - S Boveda
- Clinique Pasteur, Department of Cardiology, 31076 Toulouse, France
| | - A Jacquier
- Université Aix-Marseille, Centre Hospitalo-Universitaire Timone, AP-HM, Department of Radiology, CNRS, CRMBM, CEMEREM, 13005 Marseille, France
| |
Collapse
|
13
|
Bah MG, Rodriguez D, Cazeneuve C, Mochel F, Devos D, Suppiej A, Roubertie A, Meunier I, Gitiaux C, Curie A, Klapczynski F, Allani‐Essid N, Carneiro M, Van Minkelen R, Kievit A, Fluss J, Leheup B, Ratbi L, Héron D, Gras D, Do Cao J, Pichard S, Strubi‐Villaume I, Audo I, Lesca G, Charles P, Dubois F, Comet‐Didierjean P, Capri Y, Barondiot C, Barathon M, Ewenczyk C, Durr A, Mignot C. Deciphering the natural history of SCA7 in children. Eur J Neurol 2020; 27:2267-2276. [DOI: 10.1111/ene.14405] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2020] [Accepted: 06/10/2020] [Indexed: 11/30/2022]
|
14
|
Fauchier L, Bisson A, Cinaud A, Brigadeau F, Lepillier A, Jacon P, Gras D, Klug D, Guedeney P, Pierre B, Mansourati J, Piot O, Montalescot G, Deharo JC, Defaye P. P999Major adverse events with percutaneous left atrial appendage closure in patients with atrial fibrillation in real life setting. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz747.0592] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Transcatheter left atrial appendage (LAA) closure is an alternative strategy for stroke prevention in atrial fibrillation (AF) patients with an inacceptable risk of bleeding with oral anticoagulation (OAC). A better characterization of major adverse clinical events after LAA closure in daily practice is still needed.
Methods
We analysed data from all AF patients treated with Watchman or Amplatzer LAA closure according to European guidelines in 8 French cardiology departments. Antithrombotic management was decided for each patient on an individual basis. A Cox regression model was used for multivariable analysis of major adverse events. Yearly rate of ischemic stroke during follow-up was calculated and compared to that expected for a same risk score population. Yearly rate of bleeding was extrapolated from that reported with the HASBLED score.
Results
A total of 469 consecutive AF patients (299 males, 74.9±8.9 years old, mean CHA2DS2-VASc score 4.5±1.4, HASBLED score 3.7±1.0) received LAA closure from March 2012 to January 2017. There were 272 Watchman devices (58%) and 197 ACP devices (42%) implanted. At discharge, 36% received a single anti platelet therapy (APT), 23% received dual APT, 29% received OAC and no APT, 5% received OAC plus APT and 8% received no antithrombotic therapy. Mean follow up was 11.4 months (median 7, interquartile 3–22 months) during which 70 major adverse events (19 ischemic strokes, 18 major haemorrhages and 33 deaths) were recorded in 69 patients. The annual rate of ischemic stroke was 3.96%, which translates into a 13% relative risk reduction (95% CI −59 to 52%) as compared with the calculated stroke rate for similar CHA2DS2-VASc score after adjustment for exposure to APT and OAC. The annual rate of major bleeding in the study was 3.75%, which corresponds to a 48% relative risk reduction (95% CI 9 to 70%) as compared with the rate that would have been expected based on a comparable HAS-BLED score. Yearly rate of mortality was 7.4% (2.5 to 3 fold higher than in previous randomized trials) and the rate of non-cardiovascular death was 82%. None of the baseline characteristics was predictive of major adverse events, neither in univariate nor in multivariable analysis, which highlights the difficulty in identifying a risk of unfavourable outcome with simple tools.
Conclusions
AF patients treated with LAA closure may have a lower risk of stroke and bleeding events compared to their theoretical risk. However, our findings indicate that a high rate of major adverse events is observed in these patients during follow-up. This questions the suggested cost-effectiveness of the procedure (with models based on previous trials) for a real-life perspective. A better identification of patients with a relevant benefit of LAA closure is needed among those with long-term anticoagulation contraindication, both for an optimal management of each patient on an individual basis and for a global perspective with limited healthcare resources.
Collapse
Affiliation(s)
- L Fauchier
- Tours Regional University Hospital, Hospital Trousseau, Tours, France
| | - A Bisson
- Tours Regional University Hospital, Hospital Trousseau, Tours, France
| | - A Cinaud
- Tours Regional University Hospital, Hospital Trousseau, Tours, France
| | | | - A Lepillier
- Centre Cardiologique du Nord (CCN), Saint Denis, France
| | - P Jacon
- University Hospital of Grenoble, Grenoble, France
| | - D Gras
- Nouvelles Cliniques Nantaises, Nantes, France
| | - D Klug
- Hospital of Lille, Lille, France
| | - P Guedeney
- Hospital Pitie-Salpetriere, Paris, France
| | - B Pierre
- University Hospital of Grenoble, Grenoble, France
| | | | - O Piot
- Centre Cardiologique du Nord (CCN), Saint Denis, France
| | | | - J C Deharo
- Hospital La Timone of Marseille, Marseille, France
| | - P Defaye
- University Hospital of Grenoble, Grenoble, France
| |
Collapse
|
15
|
Gras D, Ploux MD, Babuty MD, Guyomar MD, Bongiorni MD, Blangy MD. P5687CRT-D device replacement strategy according to previous ventricular tachycardia events: Preliminary Results of the BioCONTINUE Study. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
The need for ICD back-up may be questionable in candidates for CRT-D device replacement, who no longer meet ICD criteria due to an improved left ventricular ejection fraction (LVEF) and/or an event-free CRT-D service life.
Purpose
To evaluate the clinical relevance of ICD back-up after CRT-D device replacement in patients with primary prevention ICD indication and to investigate factors predictive of ventricular arrhythmic events (VAE).
Methods
BioCONTINUE is an observational, multicentre, prospective and international trial. Patients were enrolled after CRT-D replacement and are currently followed up to a minimum of 2 years. We investigated the rate of patients with at least 1 sustained VAE, as defined by ventricular tachycardia >30s and/or ventricular arrhythmic event treated either by ATP or shock. Predictive factors of VAE were evaluated using univariate analyses based on demographics and clinical variables observed at enrolment, followed by a multivariate analysis. These multivariate analyses were adjusted confusion demographic or clinical covariates emerging at a p<0.2 level of significance by single variable analysis.
Results
A total of 276 patients are enrolled (70±10 years, 77% men, mean LVEF 40.6±12.6%, 23.6% secondary ICD indication). The mean FU duration at the interim analysis is 19.8±8.7 months, including 98 patients (35.5%) with a 2-year FU. The rate of patients free of VAE, is 91.2%, 88.4% and 85.1% respectively at 1, 2 and 3 years of FU. In patients with persistent ICD indication at enrolment (defined by LVEF <40% and/or previous VAE), the risk of VAE after device replacement is 3.3 times higher (95% CI: 1.4–8.2; p=0.007) than patients with no persistent ICD indication. The risk of VAE remains in patients with no persistent ICD indication, with a rate of 4.9% (95% CI 1.8%-10.4%). On multivariate analysis, age, ICD indication and ischemic heart disease, predicted VAE after the device replacement, with HR 0.96 (95% CI: 0.92–0.99; p=0.02), HR 3.01 (95% CI: 1.21–7.46; p=0.02) and HR 3.60 (95% CI: 1.54–8.42; p=0.003) respectively.
Conclusions
The interim results of the BioCONTINUE trial show a persistent risk of VAE after CRT-D device replacement, both in patients with and without persistent ICD indication. The risk of VAE is dependent on age, ICD indication and ischemic heart disease.
Acknowledgement/Funding
Supported by Biotronik
Collapse
Affiliation(s)
- D Gras
- Hopital Prive du Confluent, Nantes, France
| | - M D Ploux
- Hospital Haut Leveque, Bordeaux-Pessac, France
| | - M D Babuty
- Centre Hospitalier Universitaire, Tours, France
| | - M D Guyomar
- Centre Hospitalier Saint Philibert, Lomme, France
| | | | - M D Blangy
- Hospital Brabois of Nancy, Vandoeuvre les Nancy, France
| |
Collapse
|
16
|
Marijon E, Garcia R, Gras D, Sadoul N, Guedon-Moreau L, Leclercq C, Extramiana F, Lellouche N, Defaye P, Combes N. 2404The use of wearable cardioverter defibrillator in France. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.0157] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
The wearable cardioverter defibrillator (WCD) has been shown to be useful during transient periods of high sudden cardiac death risk, and the issue of compliance recently pointed out. This Registry was designed to provide real-world data on WCD use in France, in terms of compliance, potential adverse events, as well as efficacy.
Methods and results
Multicenter evaluation (WEARIT FRANCE Registry) was conducted in France between January 2017 and March 2018. Overall, 1,157 patients were analyzed: 950 with ischemic heart disease (82%, including 647 patients after myocardial infarction), 119 after ICD explant (10%), and 88 pre-transplant (8%). The median age was 61 years; the median ejection fraction was 25%. Median WCD wear time was 62 days, with median daily use of 23.4 hours. Less than 1% of patients did not wear WCD at least 4 hours per day. During follow-up, a total of 42 sustained ventricular tachyarrhythmias (VT/VF) occurred in 36 patients, of whom 50% (n=18) received appropriate WCD shocks, giving an incidence of appropriate therapy of 1.56%. The rate of all VT/VF episodes were 3.1% among patients with ischemic cardiomyopathy (n=29/950) versus 3.4% for the others (n=7/207). Of the ischemic patients wearing beyond 30 days (N=784), 5 received appropriate therapy of VT/VF episodes. Overall shock survival was 100%. At the end of the WCD period, 586 patients (51%) were implanted with an implantable cardioverter defibrillator. Eight patients (0.69%) received inappropriate WCD shocks. Regarding the apparent very low proportion of women considered for WCD therapy, we aimed to appreciate in which extent
Conclusions
In this multicenter nationwide WCD evaluation, 3.1% of patients presented with sustained VT/VF with 47% of those patients developing VT/VF after 30 days. The incidence of inappropriate therapy was low. The compliance to WCD in this real life evaluation was very high. These data suggest that the WCD, when worn appropriately, may be helpful in the arsenal to protect high-risk patients against SCD, especially in case of transient risk situations.
Acknowledgement/Funding
Zoll
Collapse
Affiliation(s)
- E Marijon
- University Paris-Descartes, Paris, France
| | - R Garcia
- University Hospital of Poitiers, Poitiers, France
| | - D Gras
- Nouvelles Cliniques Nantaises, Nantes, France
| | - N Sadoul
- Hospital Brabois of Nancy, Vandoeuvre les Nancy, France
| | | | - C Leclercq
- University Hospital of Rennes, Rennes, France
| | | | | | - P Defaye
- University Hospital of Grenoble, Grenoble, France
| | - N Combes
- Clinic Pasteur, Toulouse, France
| |
Collapse
|
17
|
Fauchier L, Cinaud A, Brigadeau F, Guedeney P, Jacon P, Mansourati J, Deharo JC, Franceschi F, Pierre B, Klug D, Lepillier A, Piot O, Gras D, Montalescot G, Defaye P. P4809Possible benefits of left atrial appendage closure for stroke prevention in patients with atrial fibrillation in real life setting. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p4809] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- L Fauchier
- Tours Regional University Hospital, Hospital Trousseau, Tours, France
| | - A Cinaud
- Tours Regional University Hospital, Hospital Trousseau, Tours, France
| | | | - P Guedeney
- Hospital Pitie-Salpetriere, Paris, France
| | - P Jacon
- University Hospital of Grenoble, Grenoble, France
| | | | - J C Deharo
- Hospital La Timone of Marseille, Marseille, France
| | - F Franceschi
- Hospital La Timone of Marseille, Marseille, France
| | - B Pierre
- Tours Regional University Hospital, Hospital Trousseau, Tours, France
| | - D Klug
- Cardiology Hospital of Lille, Lille, France
| | - A Lepillier
- Centre Cardiologique du Nord, Saint Denis, France
| | - O Piot
- Centre Cardiologique du Nord, Saint Denis, France
| | - D Gras
- Nouvelles Cliniques Nantaises, Nantes, France
| | | | - P Defaye
- University Hospital of Grenoble, Grenoble, France
| |
Collapse
|
18
|
Fauchier L, Cinaud A, Lepillier A, Brigadeau F, Jacon P, Pierre B, Paziaud O, Franceschi F, Mansourati J, Klug D, Piot O, Gras D, Montalescot G, Deharo JC, Defaye P. 201Left atrial appendage closure for stroke prevention in patients with atrial fibrillation: the difficult task of estimating the possible benefit in real life setting. Europace 2018. [DOI: 10.1093/europace/euy015.050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- L Fauchier
- Tours Regional University Hospital, Hospital Trousseau, Tours, France
| | - A Cinaud
- Tours Regional University Hospital, Hospital Trousseau, Tours, France
| | - A Lepillier
- Centre Cardiologique du Nord, Saint Denis, France
| | | | - P Jacon
- University Hospital of Grenoble, Grenoble, France
| | - B Pierre
- Tours Regional University Hospital, Hospital Trousseau, Tours, France
| | - O Paziaud
- Centre Cardiologique du Nord, Saint Denis, France
| | - F Franceschi
- Hospital La Timone of Marseille, Marseille, France
| | | | - D Klug
- Cardiology Hospital of Lille, Lille, France
| | - O Piot
- Centre Cardiologique du Nord, Saint Denis, France
| | - D Gras
- Nouvelles Cliniques Nantaises, Nantes, France
| | | | - J C Deharo
- Hospital La Timone of Marseille, Marseille, France
| | - P Defaye
- University Hospital of Grenoble, Grenoble, France
| |
Collapse
|
19
|
Pahus L, Gouitaa M, Sofalvi T, Alagha K, Gras D, Chanez P, Charpin D. Cypress pollen allergy is responsible for two distinct phenotypes of allergic rhinitis different from other pollinosis. Eur Ann Allergy Clin Immunol 2018; 50:28-35. [PMID: 29350019 DOI: 10.23822/eurannaci.1764-1489.34] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Summary Different phenotypes of allergic rhinitis have been identified based on the seasonality of the allergen involved. Within pollinosis, importance has to be paid to the responsible pollen species. Guidelines for clinical management are mostly based on studies performed in patients with grass pollen allergy. Only few data is available on tree pollen allergy and more specifically on cypress pollen allergy. We focused on the clinical and biological features of cypress pollen allergy to determine whether it is associated with a specific phenotype of allergic rhinitis or not. Our results suggest that cypress pollen can be responsible for two distinct phenotypes of rhinitis, both different from other pollinosis. In the most common phenotype, cypress pollen was not responsible for bronchial hyperresponsiveness or systemic inflammation. Close attention has to be paid to the allergen involved in allergic rhinitis. Different phenotypes leading to different pharmacological strategies may apply.
Collapse
Affiliation(s)
- L Pahus
- Aix Marseille Univ, APHM, Espace Éthique Méditerranéen, UMR 7268 ADES / EFS / CNRS, CIC 9502, Clinique des bronches allergies et sommeil Hôpital Nord, 4eme B Chemin des Bourrely 13015 Marseille Phone: +33 04 919 658 64 Fax: +33 04 919 689 02 E-mail:
| | - M Gouitaa
- APHM, Clinique des bronches allergies et sommeil, Marseille, France
| | - T Sofalvi
- APHM, Clinique des bronches allergies et sommeil, Marseille, France
| | - K Alagha
- APHM, Clinique des bronches allergies et sommeil, Marseille, France
| | - D Gras
- UMR INSERM 1067 / CNRS 7333, Marseille, France
| | - P Chanez
- Aix Marseille Univ, APHM, UMR CNRS 7333, CIC 9502, INSERM U1067, Clinique des bronches allergies et sommeil, Marseille, France
| | - D Charpin
- APHM, Pneumology Unit, Hôpital de la Timone, Marseille, France Study conducted in APHM, Clinique des Bronches, allergies et sommeil, Marseille France
| |
Collapse
|
20
|
Bun S, Latcu D, Anselme F, Boveda S, Cebron J, Delaye P, Deharo J, Gandjbakhch E, Gras D, Klug D, Mansourati J, Marijon E, Maury P, Taghji P, Saoudi N, Taieb J. How is contact force implemented in routine clinical practice? Results from a French National Survey. Archives of Cardiovascular Diseases Supplements 2018. [DOI: 10.1016/j.acvdsp.2017.11.249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
21
|
Hotier S, Leroy F, Boisgontier J, Laidi C, Mangin JF, Delorme R, Bolognani F, Czech C, Bouquet C, Toledano E, Bouvard M, Petit J, Mishchenko M, d'Albis MA, Gras D, Gaman A, Scheid I, Leboyer M, Zalla T, Houenou J. Social cognition in autism is associated with the neurodevelopment of the posterior superior temporal sulcus. Acta Psychiatr Scand 2017; 136:517-525. [PMID: 28940401 DOI: 10.1111/acps.12814] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 08/29/2017] [Indexed: 12/23/2022]
Abstract
OBJECTIVE The posterior superior temporal sulcus (pSTS) plays a critical role in the 'social brain'. Its neurodevelopment and relationship with the social impairment in autism spectrum disorders (ASD) are not well understood. We explored the relationship between social cognition and the neurodevelopment of the pSTS in ASD. METHOD We included 44 adults with high-functioning ASD and 36 controls. We assessed their performances on the 'Reading the mind in the eyes' test (for 34 of 44 subjects with ASD and 30 of 36 controls), their fixation time on the eyes with eye tracking (for 35 of 44 subjects with ASD and 30 of 36 controls) and the morphology of the caudal branches of the pSTS (length and depth), markers of the neurodevelopment, with structural MRI. RESULTS The right anterior caudal ramus of the pSTS was significantly longer in patients with ASD compared with controls (52.6 mm vs. 38.3 mm; P = 1.4 × 10-3 ; Cohen's d = 0.76). Its length negatively correlated with fixation time on the eyes (P = 0.03) in the ASD group and with the 'Reading the mind in the eyes' test scores in both groups (P = 0.03). CONCLUSION Our findings suggest that the neurodevelopment of the pSTS is related to the ASD social impairments.
Collapse
Affiliation(s)
- S Hotier
- UNIACT, Psychiatry Team, Neurospin Neuroimaging Platform, CEA Saclay, Gif-Sur-Yvette, France
- INSERM U955, Mondor Institute for Biomedical Research, Team 15, Translational Psychiatry, Créteil, France
- Fondation Fondamental, Créteil, France
- Psychiatry Department, Charles Nicolle University Hospital, Rouen, France
- DHU PePSY, Department of Psychiatry, Assistance Publique-Hôpitaux de Paris (AP-HP), Mondor University Hospitals, Créteil, France
- Faculty of Medicine, Paris East University, Créteil, France
| | - F Leroy
- INSERM, U992, UNICOG, NeuroSpin Neuroimaging Platform, University Paris Saclay, CEA Saclay, Gif-Sur-Yvette, France
| | - J Boisgontier
- UNIACT, Psychiatry Team, Neurospin Neuroimaging Platform, CEA Saclay, Gif-Sur-Yvette, France
- INSERM U955, Mondor Institute for Biomedical Research, Team 15, Translational Psychiatry, Créteil, France
- Fondation Fondamental, Créteil, France
| | - C Laidi
- UNIACT, Psychiatry Team, Neurospin Neuroimaging Platform, CEA Saclay, Gif-Sur-Yvette, France
- INSERM U955, Mondor Institute for Biomedical Research, Team 15, Translational Psychiatry, Créteil, France
- Fondation Fondamental, Créteil, France
- DHU PePSY, Department of Psychiatry, Assistance Publique-Hôpitaux de Paris (AP-HP), Mondor University Hospitals, Créteil, France
| | - J-F Mangin
- UNATI, Neurospin Neuroimaging Platform, CEA Saclay, Gif-Sur-Yvette, France
| | - R Delorme
- Fondation Fondamental, Créteil, France
- Child and Adolescent Psychiatry Department, Assistance Publique-Hôpitaux de Paris (AP-HP), Robert Debré Hospital, Paris, France
- Institut Pasteur, Human Genetics and Cognitive Functions Unit, Paris, France
| | - F Bolognani
- Neuroscience, Ophthalmology, and Rare Diseases (NORD), Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
| | - C Czech
- Neuroscience, Ophthalmology, and Rare Diseases (NORD), Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
| | - C Bouquet
- Neuroscience, Ophthalmology, and Rare Diseases (NORD), Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
| | - E Toledano
- Institut Roche, Roche Pharmaceuticals, Boulogne-Billancourt, France
| | - M Bouvard
- Fondation Fondamental, Créteil, France
- Children and Adolescent Psychiatry Department, Bordeaux University Hospital, Bordeaux, France
| | - J Petit
- Fondation Fondamental, Créteil, France
- DHU PePSY, Department of Psychiatry, Assistance Publique-Hôpitaux de Paris (AP-HP), Mondor University Hospitals, Créteil, France
| | - M Mishchenko
- Jean Nicod Institute, Centre National de la Recherche Scientifique, Ecole Normale Supeérieure, PSL, Research University, Paris, France
- Laboratory of Psychopathology and Health Processes (EA 4057), Paris Descartes University, Sorbonne Paris Cité, France
| | - M-A d'Albis
- UNIACT, Psychiatry Team, Neurospin Neuroimaging Platform, CEA Saclay, Gif-Sur-Yvette, France
- INSERM U955, Mondor Institute for Biomedical Research, Team 15, Translational Psychiatry, Créteil, France
- Fondation Fondamental, Créteil, France
- DHU PePSY, Department of Psychiatry, Assistance Publique-Hôpitaux de Paris (AP-HP), Mondor University Hospitals, Créteil, France
| | - D Gras
- Fondation Fondamental, Créteil, France
- Jean Nicod Institute, Centre National de la Recherche Scientifique, Ecole Normale Supeérieure, PSL, Research University, Paris, France
- Laboratoire de Linguistique Formelle, CNRS, Paris Diderot University, Paris, France
| | - A Gaman
- INSERM U955, Mondor Institute for Biomedical Research, Team 15, Translational Psychiatry, Créteil, France
- Fondation Fondamental, Créteil, France
- DHU PePSY, Department of Psychiatry, Assistance Publique-Hôpitaux de Paris (AP-HP), Mondor University Hospitals, Créteil, France
| | - I Scheid
- INSERM U955, Mondor Institute for Biomedical Research, Team 15, Translational Psychiatry, Créteil, France
- Fondation Fondamental, Créteil, France
- DHU PePSY, Department of Psychiatry, Assistance Publique-Hôpitaux de Paris (AP-HP), Mondor University Hospitals, Créteil, France
- Child and Adolescent Psychiatry Department, Assistance Publique-Hôpitaux de Paris (AP-HP), Robert Debré Hospital, Paris, France
| | - M Leboyer
- INSERM U955, Mondor Institute for Biomedical Research, Team 15, Translational Psychiatry, Créteil, France
- Fondation Fondamental, Créteil, France
- DHU PePSY, Department of Psychiatry, Assistance Publique-Hôpitaux de Paris (AP-HP), Mondor University Hospitals, Créteil, France
- Faculty of Medicine, Paris East University, Créteil, France
| | - T Zalla
- Fondation Fondamental, Créteil, France
- Jean Nicod Institute, Centre National de la Recherche Scientifique, Ecole Normale Supeérieure, PSL, Research University, Paris, France
| | - J Houenou
- UNIACT, Psychiatry Team, Neurospin Neuroimaging Platform, CEA Saclay, Gif-Sur-Yvette, France
- INSERM U955, Mondor Institute for Biomedical Research, Team 15, Translational Psychiatry, Créteil, France
- Fondation Fondamental, Créteil, France
- DHU PePSY, Department of Psychiatry, Assistance Publique-Hôpitaux de Paris (AP-HP), Mondor University Hospitals, Créteil, France
- Faculty of Medicine, Paris East University, Créteil, France
| |
Collapse
|
22
|
Fauchier L, Cinaud A, Brigadeau F, Pierre B, Lepillier A, Paziaud O, Fatemi M, Jacon P, Abbey S, Franceschi F, Klug D, Mansourati J, Deharo J, Gras D, Defaye P. P4562Predictors of cardiovascular events in patients with atrial fibrillation after left atrial appendage closure for stroke prevention in a multicenter analysis. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx504.p4562] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
23
|
Fauchier L, Cinaud A, Brigadeau F, Pierre B, Lepillier A, Paziaud O, Fatemi M, Jacon P, Abbey S, Franceschi F, Klug D, Mansourati J, Deharo J, Gras D, Defaye P. 5718Incidence, predictors and prognosis of thrombus formation on device in patients with atrial fibrillation after left atrial appendage occlusion for stroke prevention in a multicenter analysis. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx493.5718] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
24
|
Bun SS, Latcu DG, Anselme F, Boveda S, Deharo JC, Defaye P, Fauchier L, Gras D, Klug D, Mansourati J, Marijon E, Maury P, Taghji P, Saoudi N, Taieb J. P1404Contact force implementation in routine clinical practice: results from a french national survey. Europace 2017. [DOI: 10.1093/ehjci/eux158.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
25
|
Charpin D, Pahus L, Sofalvi T, Gras D, Gouitaa M, Chanez P. Absence d’augmentation de la réactivité bronchique à la méthacholine durant la saison pollinique chez les patients allergies au pollen de cyprès. Rev Mal Respir 2016. [DOI: 10.1016/j.rmr.2015.10.085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
26
|
Schuijs MJ, Willart MA, Vergote K, Gras D, Deswarte K, Ege MJ, Madeira FB, Beyaert R, van Loo G, Bracher F, von Mutius E, Chanez P, Lambrecht BN, Hammad H. Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells. Science 2015; 349:1106-10. [DOI: 10.1126/science.aac6623] [Citation(s) in RCA: 393] [Impact Index Per Article: 43.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
|
27
|
Bonheur J, Gras D, Bulteau C, Boespflug-Tanguy O. P-467 – Description phénotypique d'une cohorte de 110 enfants dyspraxiques suivis à l'hôpital Robert Debré. Arch Pediatr 2015. [DOI: 10.1016/s0929-693x(15)30644-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
28
|
Khelloufi MK, Garulli C, Viallat A, Chanez P, Gras D. L’organisation spatiale de touffes de cils gouverne le transport de mucus dans les voies aériennes. Application à l’asthme sévère. Rev Mal Respir 2015. [DOI: 10.1016/j.rmr.2015.02.072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
29
|
Rinaldi CA, Burri H, Thibault B, Curnis A, Rao A, Gras D, Sperzel J, Singh JP, Biffi M, Bordachar P, Leclercq C. A review of multisite pacing to achieve cardiac resynchronization therapy. Europace 2014; 17:7-17. [DOI: 10.1093/europace/euu197] [Citation(s) in RCA: 53] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
30
|
Carsin A, Oudyi M, Dubus JC, De Blic J, De Lagausie P, Chanez P, Gras D. Effet in vitro des corticoïdes inhalés sur l’activation viro-induite des cellules épithéliales bronchiques d’enfants asthmatiques. Rev Mal Respir 2014. [DOI: 10.1016/j.rmr.2014.04.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
31
|
Khelloufi MK, Garulli C, Viallat A, Chanez P, Gras D. Activité mucociliaire dans l’asthme sévère. Approche in vitro. Rev Mal Respir 2014. [DOI: 10.1016/j.rmr.2014.04.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
32
|
Froidure A, Shen C, Gras D, Van Snick J, Chanez P, Pilette C. Myeloid dendritic cells are primed in allergic asthma for thymic stromal lymphopoietin-mediated induction of Th2 and Th9 responses. Allergy 2014; 69:1068-76. [PMID: 24888572 DOI: 10.1111/all.12435] [Citation(s) in RCA: 54] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/23/2014] [Indexed: 12/20/2022]
Abstract
BACKGROUND Type 1 myeloid dendritic cells (mDCs) contribute to inception of allergic asthma (AA) and are regulated by epithelial-derived cytokines. OBJECTIVES To evaluate whether mDCs from AA patients are primed for thymic stromal lymphopoietin (TSLP)-driven responses. METHODS mDCs from 18 AA patients and 15 controls were purified using immunomagnetic sorting. Cells were pulsed with TSLP or Dermatophagoides pteronyssinus (Der p) allergen, before FACS phenotyping and co-culture with allogeneic CD4+ T cells. Bronchial biopsies from 15 AA patients and four controls were immunostained for CD1c and TSLP receptor (TSLPR). RESULTS Allergic asthma patients had a higher proportion of TSLPR+ mDCs, in blood and bronchial mucosa. When compared to mDCs from controls, both TSLP- and Der p-pulsed blood mDCs from AA patients induced increased polarization of CD4+ T cells into Th2 cells (IL-5, IL-13, and GATA3+), while only TSLP-mDCs promoted Th9 cells (IL-9 and PU.1+ /IRF4+). In addition, OX40L was induced upon TSLP stimulation and was required for the induction of Th2, but not Th9, cells. In contrast, development of Th9 cells in this model depended on TGF-β1. CONCLUSIONS Our data indicate overlapping but partially distinct effects of TSLP and Der p allergen pathways, showing that DCs are primed in human asthma for TSLP-driven induction of both Th2 and Th9 cells. This novel TSLP/mDC/Th9 axis operates through a distinct, OX40L-independent pathway. These data further highlight the TSLP pathway as a relevant target in human asthma.
Collapse
Affiliation(s)
- A. Froidure
- Institut de Recherche Expérimentale et Clinique; Université Catholique de Louvain and Walloon Institute for Excellence in Lifesciences and Biotechnology (WELBIO); Brussels Belgium
- Cliniques Universitaires Saint-Luc; service de Pneumologie; Brussels Belgium
| | - C. Shen
- Institut de Recherche Expérimentale et Clinique; Université Catholique de Louvain and Walloon Institute for Excellence in Lifesciences and Biotechnology (WELBIO); Brussels Belgium
| | - D. Gras
- INSERM U 1067; CNRS UMR 7333 Aix Marseille Université; Marseille France
| | - J. Van Snick
- Ludwig Institute for Cancer Research; Brussels Belgium
| | - P. Chanez
- INSERM U 1067; CNRS UMR 7333 Aix Marseille Université; Marseille France
- Département des Maladies Respiratoires; Assistance Publique des Hôpitaux de Marseille; Marseille France
| | - C. Pilette
- Institut de Recherche Expérimentale et Clinique; Université Catholique de Louvain and Walloon Institute for Excellence in Lifesciences and Biotechnology (WELBIO); Brussels Belgium
- Cliniques Universitaires Saint-Luc; service de Pneumologie; Brussels Belgium
| |
Collapse
|
33
|
Gagliardo R, Chanez P, Gjomarkaj M, La Grutta S, Bonanno A, Montalbano AM, Di Sano C, Albano GD, Gras D, Anzalone G, Riccobono L, Profita M. The role of transforming growth factor-β1 in airway inflammation of childhood asthma. Int J Immunopathol Pharmacol 2014; 26:725-38. [PMID: 24067469 DOI: 10.1177/039463201302600316] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023] Open
Abstract
TGF-beta-targeting structural and inflammatory cells has been implicated in the mechanisms leading to the inflammatory and restructuring processes in asthma, suggesting an impact of TGF-beta1 signaling on the development and persistency of this disease. We investigated the potential early involvement of TGF-beta1 activity in the immunological and molecular mechanisms underlying progression of inflammation in childhood asthma. We evaluated the levels of TGF-beta1 in induced sputum supernatants (ISSs) and the expression of small mother cell against decapentaplegic (Smad) 2 and Smad7 proteins in induced sputum cells (ISCs) from children with intermittent asthma (IA), moderate asthma (MA) and control subjects (C). Furthermore, we investigated the regulatory role of TGF-beta1 activity on eosinophil and neutrophil adhesion to epithelial cells using adhesion assay, and on the granulocyte expression of adhesion molecule CD11b/CD18 Macrophage-1 antigen (MAC-1), by flow cytometry. We found that the levels of TGF-beta1 are increased in ISSs of IA and MA in comparison to C, concomitantly to the activation of intracellular signaling TGFbeta/Smads pathway in ISCs. In MA, TGF-beta1 levels correlated with the number of sputum eosinophils and neutrophils. Furthermore, we showed the ability of sputum TGF-beta1 to promote eosinophil and neutrophil adhesion to epithelial cells, and to increase the expression of MAC-1 on the granulocyte surface. This study shows the activation of TGFbeta/Smad signaling pathway in the airways of children with IA and, despite the regular ICS treatment, in children with MA, and provides evidence for the contribution of TGF-beta1 in the regulation of granulocyte activation and trafficking.
Collapse
Affiliation(s)
- R Gagliardo
- Institute of Biomedicine and Molecular Immunology, Unit of Immunopathology and Pharmacology of the Respiratory System, A. Maurizio Vignola Laboratories, Italian National Research Council, Palermo, Italy
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
34
|
Arbelo E, Brugada J, Hindricks G, Maggioni AP, Tavazzi L, Vardas P, Laroche C, Anselme F, Inama G, Jais P, Kalarus Z, Kautzner J, Lewalter T, Mairesse GH, Perez-Villacastin J, Riahi S, Taborsky M, Theodorakis G, Trines SA, Brugada J, Arbelo E, Hindriks G, Maggioni AP, Morgan J, Tavazzi L, Vardas P, Alonso A, Ferrari R, Komajda M, Tavazzi L, Wood D, Vardas P, Brugada J, Mairesse G, Taborsky M, Kautzner J, Lewalter T, Riahi S, Jais P, Anselme F, Theodorakis G, Inama G, Trines S, Kalarus Z, Villacastin JP, Maggioni AP, Manini M, Gracia G, Laroche C, Missiamenou V, Taylor C, Konte M, Fiorucci E, Lefrancq EF, Glémot M, McNeill PA, Bois T, Heidbüchel H, Nuyens D, Boland J, Dinraths V, Herzet JM, Hoffer E, Malmendier D, Massoz M, Pourbaix S, Ballant E, Blommaert D, Deceuninck O, Dormal F, Xhaet O, De Potter T, Geelen P, Derycker K, Duytschaever M, Tavernier R, Vandekerckhove Y, Vankats D, Bulava A, Hanis J, Sitek D, Blahova M, Cihak R, Hanyasova L, Jansova H, Peichl P, Tanzerova M, Wichterle D, Duda J, Haman L, Parizek P, Coling L, Neuzil P, Petru J, Sediva L, Skoda J, Chovancik J, Fiala M, Neuwirth R, Karlsdottir A, Pehrson S, Gerdes C, Jensen H, Lukac P, Nielsen JC, Hansen J, Johannessen A, Hansen PS, Pedersen A, Heath F, Hjortshoj S, Thogersen A, Da Costa A, Martel I, Romeyer-Bouchard C, Sadki N, Schmid A, Haissaguerre M, Hocini M, Knecht S, Sacher F, Ait Said M, Cauchemez B, Ledoux F, Thomas O, Cebron JP, Decarsin N, Gras D, Hervouet S, Durand C, Durand-Dubief A, Poty H, Babuty D, Pierre B, Albenque JP, Boveda S, Combes N, Mas R, Hermida JS, Kubala M, Godin B, Savouré A, Soublin Y, Defaye P, Jacon P, Brigadeau F, Corbut S, Flament-Balzola F, Kacet S, Klug D, Lacroix D, Copie X, Gilles L, Hocine Z, Paziaud O, Piot O, Crocq C, Kaballu G, Le Moal V, Lotton P, Mabo P, Pavin D, Andronache M, De Chillou C, Magnin-Poull I, Deharo JC, Durand C, Franceschi F, Peyrouse E, Prevot S, Etchegoin M, Extramiana F, Leenhardt A, Messali A, Heine T, Schneider A, Winter N, Brachmann J, Ritscher G, Schertel-Gruenler B, Simon H, Sinha AM, Turschner O, Wystrach A, Stemberg M, Kuck KH, Metzner A, Tilz R, Wissner E, Heitmann K, Willems S, Andresen D, Mueller S, Volkmer M, Schmidt B, Kostopoulou A, Livanis E, Voudris V, Efremidis M, Letsas K, Tsikrikas S, Christoforatou E, Ioannidis P, Katsivas A, Kourouklis S, Andrikopoulos G, Rassias I, Tzeis S, Dakos G, Paraskevaidis S, Stavropoulos G, Theofilogiannakos E, Vassilikos V, Bongiorni M, Zucchelli G, Raviele A, Themistoclakis S, Pratola C, Tritto M, Della Bella P, Mazzone P, Moltrasio M, Tondo C, Calo L, De Luca L, Guarracini F, Lioy E, Dozza L, Frigoli E, Giannelli L, Pappone C, Saviano M, Schiavina G, Vicedomini G, De Ponti R, Doni LA, Marazzi R, Salerno-Uriarte J, Tamborini C, Anselmino M, Ferraris F, Gaita F, Bertaglia E, Brandolino G, Zoppo F, De Groot N, Janse P, Jordaens L, Pison L, Roos C, Van Gelder I, Manusama R, Meijer A, Van der Voort P, Trines S, Compier MG, Kazmierczak J, Kornacewicz-Jach Z, Wielusinski M, Baran J, Kulakowski P, Dzidowski M, Fuglewicz A, Nowak K, Pruszkowska-Skrzep P, Wozniak A, Nowak S, Trusz-Gluza M, Almendral J, Atienza F, Castellanos E, De Diego C, Ortiz M, Moreno Planas J, Perez Castellano N, Benezet J, Farre Muncharaz J, Rubio Campal J, Hernandez Madrid A, Matia R, Arana E, Pedrote A, Cozar R, Peinado R, Valverde I, Arbelo E, Berruezo A, Calvo N, Guiu E, Husseini S, Mont Girbau L. The Atrial Fibrillation Ablation Pilot Study: an European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association. Eur Heart J 2014; 35:1466-78. [DOI: 10.1093/eurheartj/ehu001] [Citation(s) in RCA: 151] [Impact Index Per Article: 15.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- Elena Arbelo
- Department of Cardiology, Thorax Institute, Hospital Clínic de Barcelona, C/ Villarroel 170, 6° - Escala 3, 08036, University of Barcelona, Barcelona, Spain
| | - Josep Brugada
- Department of Cardiology, Thorax Institute, Hospital Clínic de Barcelona, C/ Villarroel 170, 6° - Escala 3, 08036, University of Barcelona, Barcelona, Spain
| | | | - Aldo P. Maggioni
- EURObservational Research Programme, European Society of Cardiology, Sophia – Antipolis, France
| | - Luigi Tavazzi
- GVM Care and Research, E.S. Health Science Foundation, Maria Cecilia Hospital, Cotignola, Italy
| | - Panos Vardas
- Department of Cardiology, Heraklion University Hospital, Crete, Greece
| | - Cécile Laroche
- EURObservational Research Programme, European Society of Cardiology, Sophia – Antipolis, France
| | - Frédéric Anselme
- Service De Cardiologie, Hôpital Charles Nicolle, Rouen Cedex, France
| | | | - Pierre Jais
- Hôpital Cardiologique du Haut-Lévêque, Bordeaux-Pessac, France
| | - Zbigniew Kalarus
- Department of Cardiology, Silesian Academy of Medicine, Zabrze, Poland
| | - Josef Kautzner
- Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
| | | | | | | | - Sam Riahi
- AF Study Group, Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark
| | - Milos Taborsky
- Internal Cardiology Department, Faculty Hospital Olomouc, Olomouc, Czech Republic
| | | | - Serge A. Trines
- Department of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Khelloufi MK, Gras D, Garulli C, Viallat A, Chanez P. Étude de l’activité mucociliaire dans l’asthme sévère. Rev Mal Respir 2014. [DOI: 10.1016/j.rmr.2013.10.134] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
36
|
Afenjar A, Billette De Villemeur T, Chabrol B, Gras D, Legall A, Mochel F, Sedel F, Rodriguez D, Burglen L. Phénotype clinique reconnaissable des neurodegeneration with brain iron accumulation (NBIA) liées aux mutations du gène C19ORF12. Arch Pediatr 2013. [DOI: 10.1016/j.arcped.2013.01.046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
37
|
|
38
|
|
39
|
Bogale N, Priori S, Gitt A, Alings M, Linde C, Dickstein K, Dickstein K, Priori S, Auricchio A, Bogale N, Brugada J, Cleland JG, Derumeaux G, Gitt A, Gras D, Komajda M, Linde C, Morgan J, van Veldhuisen DJ, Fruhwald F, Strohmer B, Goethals M, Vijgen J, Trochu JN, Gras D, Kindermann M, Stellbrink C, McDonnald K, Keane D, Ben Gal T, Glikson M, Metra M, Gasparini M, Maass A, Jordaens L, Alings M, Larsen AI, Faerestrand S, Delgado J, Mont L, Persson H, Gadler F, Rocca HPBL, Osswald S, Squire I, Morgan J, Brant J, Gadler F, Linde C, Andresen D, Butter C, Gonska B, Jung W, Kuck KH, Senges J, Stellbrink C. The European cardiac resynchronization therapy survey: patient selection and implantation practice vary according to centre volume. Europace 2011; 13:1445-53. [DOI: 10.1093/europace/eur173] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
40
|
Wollmann CG, Globits S, Ameri L, Thudt K, Kaiser B, Salomonowitz E, Mayr H, Wilkoff B, Styperek R, Jumrussirikul P, Mirro M, Wong W, Ha K, Healey J, Kaufman ES, Nair GM, Armaganijan LV, Divakaramenon S, Mairesse GH, Brandes A, Crystal E, Tomassoni G, Ryu K, Muir M, O'brien E, Hesselson A, Greenberg S, Hamati F, Styperek R, Alonso J, Peress D, Lee L, Bolanos O, Burger H, Opalka B, Goebel G, Ehrlich W, Walther W, Ziegelhoeffer T, Milasinovic G, Quartieri F, Compton S, Kristiansen N, Li P, Ramza B, Dovellini EV, Michelucci A, Trapani M, Buonamici P, Valenti R, Antoniucci D, Hero M, Guenoun M, Ferrer Hita JJ, Rodriguez-Gonzalez A, Machado-Machado P, Perez-Hernandez LM, Raya-Sanchez JA, Lara-Padron A, Bosa-Ojeda F, Marrero-Rodriguez F, Luedorff G, Grove R, Wolff E, Thale J, Kranig W, Niazi I, Ryu K, Choudhuri I, Akhtar M, Jais P, Maury P, Reddy VY, Neuzil P, Morgan K, Bordachar P, Ritter P, Haissaguerre M, Doering M, Braunschweig F, Gaspar T, Eitel C, Wetzel U, Nitsche B, Piorkowski C, Hindricks G, Gras D, Boulogne E, Simon M, Abraham W. Flash Presentations II. Europace 2011. [DOI: 10.1093/europace/eur218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
41
|
Tada H, Yamasaki H, Sekiguchi Y, Igarashi M, Kuroki K, Machino T, Yoshida K, Aonuma K, Heinzel FR, Forstner H, Lercher P, Bisping E, Rotman B, Fruhwald FM, Pieske BM, Dabrowski R, Kowalik I, Borowiec A, Smolis-Bak E, Trybuch A, Sosnowski C, Szwed H, Baturova MA, Lindgren A, Shubik YV, Olsson B, Platonov PG, Van Den Broek KC, Denollet J, Widdershoven J, Kupper N, Allam R, Allam RAGAB, Galal WAGDY, El-Damnhoury HAYAM, Mortada AYMAN, Jimenez-Candil J, Martin A, Hernandez J, Martin F, Gallego M, Martin-Luengo C, Quintanilla JG, Moreno Planas J, Molina-Morua R, Archondo T, Garcia-Torrent MJ, Perez-Castellano N, Macaya C, Perez-Villacastin J, Saiz J, Tobon C, Rodriguez JF, Hornero F, Ferrero JM, Ito K, Date T, Kawai M, Hioki M, Narui R, Matsuo S, Yoshimura M, Yamane T, Tabatabaei N, Lin G, Powell BD, Smairat R, Glockner JF, Brady PA, Fichtner S, Czudnochowsky U, Estner H, Reents T, Jilek C, Ammar S, Hessling G, Deisenhofer I, Shah DC, Kautzner J, Saoudi N, Herrera C, Jais P, Hindricks G, Neuzil P, Kuck KH, Wong KCK, Jones M, Qureshi N, Muthumala A, Betts TR, Bashir Y, Rajappan K, Vogtmann T, Wagner M, Schurig J, Hein P, Hamm B, Baumann G, Lembcke A, Saad B, Piwowarska W, Nessler J, Edvardsson N, Rieger G, Garutti C, Linker N, Jorge C, Silva Marques J, Veiga A, Cruz J, Slater C, Correia MJ, Sousa J, Miltenberger-Miltenyi G, Nunes Diogo A, Matic D, Mrdovic I, Stankovic G, Asanin M, Antonijevic N, Matic M, Oliveira LA, Kocev N, Vasiljevic Z, Ramirez-Marrero MA, Perez-Villardon B, Delgado-Prieto JL, Jimenez-Navarro M, De Teresa-Galvan E, De Mora-Martin M, Pietrucha AZ, Bzukala I, Elias R, Sztefko K, Wnuk M, Malek A, Piwowarska W, Nessler J, Szili-Torok T, Bauernfeind T, De Groot N, Shalganov T, Schalij M, Camiletti A, Jordaens L, Rivas N, Casaldaliga J, Roca I, Pijuan A, Perez-Rodon J, Dos L, Garcia-Dorado D, Moya A, Baruteau AE, Moura D, Behaghel A, Chatel S, Mabo P, Schott JJ, Daubert JC, Le Marec H, Probst V, Zorio Grima E, Navarro-Manchon J, Molina P, Maldonado P, Igual B, Cano O, Bermejo M, Giner J, Salvador A, Bourgonje VJA, Vos MA, Ozdemir S, Doisne N, Van Der Heyden MAG, Camanho LE, Van Veen AAB, Sipido K, Antoons G, Altieri PI, Escobales N, Crespo M, Banchs HL, Sciarra L, Bloise R, Allocca G, Bulava A, Marras E, Lioy E, Delise P, Priori S, Calo' L, Hanis J, Sitek D, Novotny A, Chik WB, Lim TW, Choon HK, See VA, Mccall R, Thomas L, Ross DL, Thomas SP, Chen J, De Bortoli A, Rossvoll O, Hoff PI, Solheim E, Sun LZ, Schuster P, Ohm OJ, Ardashev AV, Zhelyakov E, Rybachenko MS, Konev AV, Belenkov YUN, Gunawardene M, Chun KRJ, Schulte-Hahn B, Windhorst V, Kulikoglu M, Nowak B, Schmidt B, Albina GA, Rivera RS, Scazzuso F, Laino RL, Giniger GA, Arbelo E, Calvo N, Tamborero D, Andreu D, Borras R, Berruezo A, Brugada J, Mont L, Stefan L, Eisenberger M, Celentano E, Peytchev P, Bodea O, Geelen P, De Potter T, Oliveira MM, Silva N, Cunha PS, Feliciano J, Lousinha A, Toste A, Santos S, Ferreira RC, Matsuda H, Harada T, Soejima K, Ishikawa Y, Mizukoshi K, Sasaki T, Mizuno K, Miyake F, Adragao PP, Cavaco D, Miranda R, Santos M, Morgado F, Reis Santos K, Candeias R, Marcelino S, Zoppo F, Grandolino G, Zerbo F, Bertaglia E, Schlueter SM, Grebe O, Vester EG, Miracle Blanco AL, Arenal Maiz A, Atienza Fernandez F, Datino Romaniega T, Gonzalez Torrecilla E, Eidelman G, Hernandez Hernandez J, Fernandez Aviles F, Fukumoto K, Takatsuki S, Kimura T, Nishiyama N, Aizawa Y, Sato T, Miyoshi S, Fukuda K, Richter B, Gwechenberger M, Socas A, Zorn G, Albinni S, Marx M, Wojta J, Goessinger H, Deneke T, Balta O, Paesler M, Buenz K, Anders H, Horlitz M, Muegge A, Shin DI, Natsuyama K, Yamaguchi KM, Nishida YN, De Bortoli A, Ohm OJ, Hoff PI, Solheim E, Schuster P, Sun LZ, Chen J, Kosiuk J, Bode K, Arya A, Piorkowski C, Gaspar T, Sommer P, Hindricks G, Bollmann A, Wichterle D, Peichl P, Simek J, Havranek S, Bulkova V, Cihak R, Kautzner J, Jurado Roman A, Salguero Bodes R, Lopez Gil M, Fontenla Cerezuela A, De Riva Silva M, Arribas Ynsaurriaga F, Fernandez Herranz AI, De Dios Perez S, Revishvili AS, Dishekov M, Tembotova Z, Barsamyan S, Vaccari D, Alvarenga C, Jesus I, Layher J, Takahashi A, Singh N, Siot P, Elkaim JP, Savelieva I, Mcclelland L, Lovegrove A, Jones S, Camm J, Folino AF, Breda R, Calzavara P, Comisso J, Borghetti F, Iliceto S, Buja G, Mlynarski R, Mlynarska A, Sosnowski M, Wilczek J, Mabo P, Carrault G, Bordachar P, Makdissi A, Duchemin L, Alonso C, Neri G, Masaro G, Vittadello S, Vaccari D, Gardin A, Barbetta A, Di Gregorio F, Sciaraffia E, Ginks MR, Gustafsson JS, Hollmark MC, Rinaldi CA, Blomstrom Lundqvist C, Brusich S, Tomasic D, Ferek-Petric B, Mavric Z, Kutarski A, Malecka B, Kolodzinska A, Grabowski M, Dovellini EV, Giurlani L, Cerisano G, Carrabba N, Valenti R, Antoniucci D, Kolodzinska A, Kutarski A, Grabowski M, Malecka B, Opolski G, Tomassoni G, Baker J, Corbisiero R, Martin D, Niazi I, Sheppard R, Sperzel J, Gutleben K, Petru J, Sediva L, Skoda J, Neuzil P, Mazzone P, Ciconte G, Vergara P, Marzi A, Paglino G, Sora N, Gulletta S, Della Bella P, Kutarski A, Pietura R, Czajkowski M, Cabanelas N, Martins VP, Alves M, Valente FX, Marta L, Francisco A, Silva R, Ferreira Da Silva G, Huo Y, Holmqvist F, Carlson J, Arya A, Wetzel U, Hindricks G, Bollmann A, Platonov P, Nof E, Abu Shama R, Kuperstein R, Feinberg MS, Eldar M, Glikson M, Luria D, Kubus P, Materna O, Gebauer RA, Matejka T, Gebauer R, Tlaskal T, Janousek J, Muessigbrodt A, Arya A, Wetzel U, Hindricks G, Richter S, Stockburger M, Boveda S, Defaye P, Stancak Branislav P, Kaliska G, Rolando M, Moreno J, Ohlow MAG, Lauer B, Buchter B, Schreiber M, Geller JC, Val-Mejias JE, Ouali S, Azzez S, Kacem S, Ben Salem H, Hammas S, Neffeti E, Remedi F, Boughzela E, Miyazaki H, Miyanaga S, Shibayama K, Tokuda M, Narui R, Kudo T, Yamane T, Yoshimura M, Coppola B, Shehada REN, Costandi P, Healey J, Hohnloser SH, Gold MR, Capucci A, Van Gelder IC, Carlson M, Lau CP, Connolly SJ, Bogaard MD, Leenders GE, Maskara B, Tuinenburg AE, Loh P, Hauer RN, Doevendans PA, Meine M, Thibault B, Dubuc M, Karst E, Ryu K, Paiement P, Farazi T, Puetz V, Berndt C, Buchholz J, Dorszewski A, Mornos C, Cozma D, Ionac A, Petrescu L, Mornos A, Pescariu S, Puetz V, Berndt C, Buchholz J, Dorszewski A, Benser M, Roscoe G, De Jong S, Roberts G, Boileau P, Rec A, Ryu K, Folman C, Morttada A, Abd El Kader M, Samir R, Roushdy R, Khaled S, Abo El Maaty M, Van Gelder B, Houthuizen P, Bracke FA, Osca Asensi J, Tejada D, Sanchez JM, Munoz B, Cano O, Rodriguez M, Sancho-Tello MJ, Olague J, Hou W, Rosenberg S, Koh S, Poore J, Snell J, Yang M, Nirav D, Bornzin G, Deering T, Dan D, Wickliffe AC, Cazeau S, Karimzadeh K, Mukerji S, Loghin C, Kantharia B, Bogaard MD, Leenders GE, Maskara B, Tuinenburg AE, Loh P, Hauer RN, Doevendans PA, Meine M, Betts TR, Jones MA, Wong KCK, Qureshi N, Rajappan K, Bashir Y, Lamba J, Simpson CS, Redfearn DP, Michael KA, Fitzpatrick M, Baranchuk A, Heinke M, Ismer B, Kuehnert H, Surber R, Haltenberger AM, Prochnau D, Figulla HR, Delarche N, Bizeau O, Couderc P, Chapelet A, Amara W, Lazarus A, Kubus P, Krupickova S, Gebauer RA, Janousek J, Van Deursen CJM, Strik M, Vernooy K, Van Hunnik A, Kuiper M, Crijns HJGM, Prinzen FW, Islam N, Gras D, Abraham W, Calo L, Birgersdotter-Green U, Clyne C, Herre J, Sheppard R, Abraham W, Gras D, Birgersdotter-Green U, Calo L, Clyne C, Klein N, Herre J, Sheppard R, Kowalski O, Lenarczyk R, Pruszkowska P, Sokal A, Kukulski T, Zielinska T, Pluta S, Kalarus Z, Schwab JO, Gasparini M, Anselme F, Clementy J, Santini M, Martinez Ferrer J, Burrone V, Santi E, Nevzorov R, Porter A, Kusniec J, Golovchiner G, Ben-Gal T, Strasberg B, Haim M, Rordorf R, Savastano S, Sanzo A, Vicentini A, Petracci B, De Amici M, Striuli L, Landolina M, Tolosana JM, Martin AM, Hernandez-Madrid A, Macias A, Fernandez-Lozano I, Osca J, Quesada A, Mont L, Igarashi M, Tada H, Yamasaki H, Sekiguchi Y, Kuroki K, Yoshida K, Noguchi Y, Aonuma K, Shahrzad S, Karim Soleiman N, Tavoosi A, Taban S, Emkanjoo Z, Fukunaga M, Goya M, Hiroshima K, Ohe M, Hayashi K, Iwabuchi M, Nosaka H, Nobuyoshi M, Doiny D, Perez-Silva A, Castrejon Castrejon S, Estrada A, Ortega M, Lopez-Sendon JL, Merino JL, Garcia Fernandez FJ, Gallardo R, Pachon M, Almendral J, Gonzalez Torrecilla E, Martin J, Yahya D, Al-Mogheer B, Gouda S, Eweis E, El Ramly M, Abdelwahab A, Kassenberg W, Wittkampf FHM, Hof IE, Heijden JH, Neven KGEJ, Meine M, Hauer RNW, Loh P, Baratto F, Bignami E, Pappalardo F, Maccabelli G, Nicolotti D, Zangrillo A, Della Bella P, Hayashi K, Goya M, Hiroshima K, Nagashima M, An Y, Fukunaga M, Okreglicki A, Russouw C, Tilz R, Yoshiga Y, Mathew S, Fuernkranz A, Rillig A, Wissner E, Kuck KH, Ouyang F, De Sisti A, Tonet J, Gueffaf F, Amara W, Touil F, Aouate P, Hidden-Lucet F, Doiny D, Castrejon Castrejon S, Estrada A, Ortega M, Perez-Silva A, Lopez-Sendon JL, Merino JL, Makimoto H, Satomi K, Yamada Y, Okamura H, Noda T, Shimizu W, Aihara N, Kamakura S, Estrada A, Perez Silva A, Doiny D, Castrejon S, Gonzalez Vasserot M, Merino JL, Tilz R, Senges J, Brachmann J, Andresen D, Hoffmann E, Schumacher B, Willems S, Kuck KH, Reents T, Deisenhofer I, Ammar S, Springer B, Fichtner S, Jilek C, Kolb C, Hessling G, Akca F, Bauernfeind T, De Groot NMS, Schwagten B, Witsenburg M, Jordaens L, Szili-Torok T, Hata Y, Nakagami R, Watanabe T, Sato A, Watanabe H, Kabutoya T, Mituhashi T, Theuns DAMJ, Smith T, Pedersen SS, Dabiri-Abkenari L, Jordaens L, Prull MW, Unverricht S, Bittlinsky A, Wirdemann H, Sasko B, Wirdeier S, Trappe HJ, Zorio Grima E, Rueda J, Medina P, Jaijo T, Sevilla T, Osca J, Arnau MA, Salvador A, Starrenburg AH, Kraaier K, Pedersen SS, Scholten MF, Van Der Palen J, De Haan S, Commandeur J, De Boer K, Beek AM, Van Rossum AC, Allaart CP, Berne P, Porres JM, Fernandez-Lozano I, Arnaiz JA, Mont L, Berruezo A, Brugada R, Brugada J, Man S, Maan AC, Thijssen J, Van Der Wall EE, Schalij MJ, Burattini L, Burattini R, Swenne CA, Bonny A, Hidden-Lucet F, Ditah I, Larrazet F, Frank R, Fontaine G, Van Den Broek KC, Pedersen SS, Theuns DAMJ, Jordaens L, Van Der Voort PH, Alings M, Denollet J, Shimane A, Okajima K, Kanda G, Yokoi K, Yamada S, Taniguchi Y, Hayashi T, Kajiya T, Santos MC, Wright J, Betts J, Denman R, Dominguez-Perez L, Arias Palomares MA, Toquero J, Jimenez-Candil J, Olague J, Diaz-Infante E, Tercedor L, Valverde I, Miracle Blanco AL, Datino Romaniega T, Arenal Maiz A, Atienza Fernandez F, Gonzalez Torrecilla E, Eidelman G, Hernandez Hernandez J, Fernandez Aviles F, Napp A, Joosten S, Stunder D, Zink M, Marx N, Schauerte P, Silny J, Trucco ME, Arce M, Palazzolo J, Femenia F, Glad JM, Szymkiewicz SJ, Glad JM, Szymkiewicz SJ, Fernandez-Armenta J, Camara O, Mont LL, Andreu D, Diaz E, Silva E, Frangi A, Berruezo A, Brembilla-Perrot B, Laporte F, Jimenez-Candil J, Martin A, Gallego M, Morinigo J, Ledesma C, Martin-Luengo C, Hadid C, Almendral J, Ortiz M, Quesada A, Wolpert C, Cobo E, Navarro X, Arribas F, Miki Y, Naitoh S, Kumagai K, Goto K, Kaseno K, Oshima S, Taniguchi K, Rivera S, Scazzuso F, Albina G, Klein A, Laino R, Sammartino V, Giniger A, Fukumoto K, Takatsuki S, Kimura T, Nishiyama N, Aizawa Y, Sato T, Miyoshi S, Fukuda K, Muggenthaler M, Raju H, Papadakis M, Chandra N, Bastiaenen R, Behr ER, Sharma S, Samniah N, Radezishvsky Y, Omari H, Rosenschein U, Perez Riera AR, Ferreira M, Hopman WM, Mcintyre WF, Baranchuk AR, Wongcharoen W, Keanprasit K, Phrommintikul A, Chaiwarith R, Yagishita A, Hachiya H, Nakamura T, Tanaka Y, Higuchi K, Kawabata M, Hirao K, Isobe M, Havranek S, Simek J, Wichterle D, Stoickov V, Ilic S, Deljanin Ilic M, Aagaard P, Sahlen A, Bergfeldt L, Braunschweig F, Sousa A, Lebreiro A, Sousa C, Oliveira S, Correia AS, Rangel I, Freitas J, Maciel MJ, Asensio Lafuente E, Aguilera AAC, Corral MACC, Mendoza KLMC, Nava PEND, Rendon ALRC, Villegas LVC, Castillo LCM, Schaerf R, Develle R, Brembilla-Perrot B, Oliver C, Zinzius PY, Providencia RA, Botelho A, Trigo J, Nascimento J, Quintal N, Mota P, Leitao-Marques AM, Borbola J, Abraham P, Foldesi CS, Kardos A, Miranda R, Almeida S, Santos MB, Cavaco D, Quaresma R, Morgado FB, Adragao P, Fatemi M, Didier R, Le Gal G, Etienne Y, Jobic Y, Gilard M, Boschat J, Mansourati J, Zubaid M, Rashed W, Alsheikh-Ali A, Almahmeed W, Shehab A, Sulaiman K, Asaad N, Amin H, Boersma LVA, Swaans M, Post M, Rensing B, Jarverud K, Broome M, Noren K, Svensson T, Hjelm S, Hollmark M, Bjorling A, Providencia RA, Botelho A, Trigo J, Nascimento J, Quintal N, Mota P, Leitao-Marques AM, Maeda K, Takagi M, Suzuki K, Tatsumi H, Yoshiyama M, Simeonidou E, Michalakeas C, Kastellanos S, Varounis C, Nikolopoulou A, Koniari C, Anastasiou-Nana M, Furukawa T, Maggi R, Bertolone C, Fontana D, Brignole M, Pietrucha AZ, Wnuk M, Bzukala I, Mroczek-Czernecka D, Konduracka E, Kruszelnicka O. Poster Session 4. Europace 2011. [DOI: 10.1093/europace/eur231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
42
|
Merrien J, Gras D, Robert P, Chanez P. [Mechanotransduction and the bronchoalveolar epithelium]. Rev Mal Respir 2010; 27:1164-74. [PMID: 21163395 DOI: 10.1016/j.rmr.2010.10.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2009] [Accepted: 06/08/2010] [Indexed: 11/25/2022]
Abstract
The bronchoalveolar epithelium is submitted to numerous mechanical strains. These strains induce a specific cellular activity at the tissue level. This type of activation has been studied in respiratory medicine, mainly in the context of mechanical ventilation and asthma. The phenomenon of mechanotransduction is linked to various epithelial cellular activities such as epithelium repair, extracellular matrix remodelling, inflammatory mediator release and mucociliary regulation. In this review, the main studies related to bronchoalveolar epithelial mechanotransduction are reported to bring a new perspective on this little known biological phenomenon. A better understanding of the physiological and pathological aspects will potentially offer new treatment approaches for bronchial diseases.
Collapse
Affiliation(s)
- J Merrien
- Département des Maladies Respiratoires, AP-HM, Université de la Méditerranée, 270 Boulevard de Sainte-Marguerite, 13009 Marseille, France.
| | | | | | | |
Collapse
|
43
|
Abstract
The relationship between allergic rhinitis and asthma is now established, and most of the clinical, epidemiological and biological data recommend integrated management. Epithelial cells represent the first barrier of the upper and lower respiratory tracts and thus are logical targets for a comprehensive integrated therapeutic approach. This review discusses rhinosinusitis as a co-morbid condition, a precipitating or triggering condition, and an epiphenomenon as an integrated part of the disease. A better understanding and a more pragmatic method of diagnosis and management is needed using cost-effective long-term strategies.
Collapse
Affiliation(s)
- A Bourdin
- Department of Respiratory Disease, CHU Arnaud de Villeneuve, Montpellier, France
| | | | | | | |
Collapse
|
44
|
Leclercq C, Padeletti L, Cihák R, Ritter P, Milasinovic G, Gras D, Paul V, Van Gelder IC, Stellbrink C, Rieger G, Corbucci G, Albers B, Daubert JC. Incidence of paroxysmal atrial tachycardias in patients treated with cardiac resynchronization therapy and continuously monitored by device diagnostics. Europace 2010; 12:71-7. [PMID: 19864311 DOI: 10.1093/europace/eup318] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
AIMS Little is known about the incidence of paroxysmal atrial tachycardias (PAT) in patients with heart failure (HF). The availability of cardiac resynchronization therapy (CRT) devices with extended diagnostics for AT enables continuous monitoring of PAT episodes. The aim of the study was to assess the incidence over time of PAT in HF patients treated with CRT. METHODS AND RESULTS Consecutive patients in NYHA functional class III or IV despite optimal drug therapy, QRS duration > or = 130 ms, left ventricular ejection fraction < or = 35%, and left ventricular end-diastolic dimension > or = 55 mm were eligible for enrolment. Patients with permanent or persistent atrial fibrillation (AF) were not included in the study. The first follow-up examination was performed 2 weeks after implantation, to optimize atrial sensing and CRT. Subsequent follow-up examinations were carried out 15 and 28 weeks after implantation, to collect the telemetric data. A total of 173 patients (67 +/- 11 years, M 116) were enrolled. Complete arrhythmia monitoring data were available from 120 patients over a mean follow-up of 183 +/- 23 days. Atrial tachycardia episodes were detected through telemetry in 25 of 120 patients (21%) during at least one follow-up examination. Atrial tachycardia episodes were recorded in 29 and 17% (P = NS) of patients with and without previous history of AF, respectively. CONCLUSION More than 20% of the overall HF patient population treated with CRT suffer PAT episodes. Paroxysmal atrial tachycardia may interfere with response to CRT. Therefore, telemetric data may be relevant to drive the appropriate therapy in each patient.
Collapse
Affiliation(s)
- C Leclercq
- Hôpital Pôntchaillou CHU, University of Rennes, Rennes, France.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Ben Ammar A, Petit F, Alexandri N, Gaudon K, Bauché S, Rouche A, Gras D, Fournier E, Koenig J, Stojkovic T, Lacour A, Petiot P, Zagnoli F, Viollet L, Pellegrini N, Orlikowski D, Lazaro L, Ferrer X, Stoltenburg G, Paturneau-Jouas M, Hentati F, Fardeau M, Sternberg D, Hantaï D, Richard P, Eymard B. Phenotype genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7. J Neurol 2009; 257:754-66. [DOI: 10.1007/s00415-009-5405-y] [Citation(s) in RCA: 47] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2009] [Revised: 10/30/2009] [Accepted: 11/16/2009] [Indexed: 10/20/2022]
|
46
|
Anselme F, Thibault B, Delay M, Mondoly P, Renesto F, Cazeau S, Burri H, Sunthorn H, Domenichini G, Stettler C, Shah D, Lee YS, Kim YN, Kim KS, Choi JY, Park HS, Kim HS, Cebron JP, Gras D, Burban M, Hero M, Tomaske M, Breithardt OA, Bauersfeld U, Prinzen FW, Mills RW, Cornelussen RN, Mulligan L, Skadsberg N, Van Hunnik A, Kuipers M, Lampert A. Abstracts: Pacing results. Europace 2009. [DOI: 10.1093/europace/euq232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
47
|
Didenko M, Stein KM, Starchik D, Khubulava G, Verlato R, Massa R, Botto G, Amellone C, Perucca A, Bongiorni MG, Piacenti M, Corbucci G, Weiss R, Rhodes T, Khoo M, Dinerman J, Oza A, Hoyt RH, Marcus RH, Mchenry B, Fedewa MM, Wiegand U, Kaplan AJ, Gras D, Cazzin R, Schwartz M, Jauvert G, Prakash A, Mansourati J, Sadoul N, Aime E, Goethals P, Bordier S, Wiegand U. Abstracts: EP meets CP: pacing for atrial fibrillation. Europace 2009. [DOI: 10.1093/europace/euq250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
48
|
Gras D, Bonnans C, Vachier I, Chanez P. Persistance phénotypique de l’asthme sévère in vitroau niveau épithélial. Rev Mal Respir 2008. [DOI: 10.1016/s0761-8425(08)74995-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
49
|
Gras D, Böcker D, Lunati M, Wellens HJJ, Calvert M, Freemantle N, Gervais R, Kappenberger L, Tavazzi L, Erdmann E, Cleland JGF, Daubert JC. Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety. ACTA ACUST UNITED AC 2007; 9:516-22. [PMID: 17540662 DOI: 10.1093/europace/eum080] [Citation(s) in RCA: 142] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
AIMS To assess procedural characteristics and adjudicated procedure-related (<or=30 days) major adverse events among patients who underwent cardiac resynchronization therapy (CRT) implantation in the CARE-HF study. The CARE-HF study shows that CRT improves symptoms and reduces morbidity and mortality in New York Heart Association (NYHA) class III/IV chronic heart failure (CHF) patients. However, safe and proper implantation of pacing systems remains key to effective CRT delivery. METHODS AND RESULTS Generalized linear modeling was used to examine the relationships between first implant success/failure and: NYHA class; beta-adrenergic blocker use; underlying ischemic vs. non-ischemic heart disease; history of coronary artery bypass graft or valve surgery; left ventricular (LV) end-diastolic volume<or=vs. >300 cm(3); and, influence of the participating study-centres. Implantation was attempted in 404/409 patients assigned to CRT, and in 65/404 patients assigned to medical therapy. Among these 469 patients, 450 (95.9%) received a successfully implanted and activated device. Complications occurred within 24 h in 47 patients (10.0%), mainly lead dislodgments (n = 10, 2.1%) and coronary sinus dissection/perforation (n = 10, 2.1%), and between 24 h and 30 days in 26 patients (5.5%), mainly lead dislodgment (n = 13, 2.8%). Mean LV lead stimulation threshold was significantly higher than at the right atrium or right ventricle, though remained stable, delivering effective, and reliable CRT. Implanting experience was the only predictor of procedural outcome. CONCLUSION Transvenous CRT system implantation, using a CS lead designed for long-term LV pacing, was safe and reliable. As implanting centres become more experienced, this success rate is expected to increase further.
Collapse
Affiliation(s)
- D Gras
- Nouvelles Cliniques Nantaises, Nantes, France
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Gras D, Bonnans C, Vachier I, Tiers L, Godard P, Lehmann S, Chanez P. 026 Effet de l’interleukine-8 (IL-8) sur les réponses des cellules épithéliales bronchiques humaines. Rev Mal Respir 2006. [DOI: 10.1016/s0761-8425(06)71854-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|